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Dissertation supervised by Dr. David Delmonico 
 Numerous research articles have reported differing data on the psychometric 
properties of the 20-item version of the Drug Abuse Screening Test (DAST-20, Skinner, 
1982a). Aggregating this diverse information can lead to a better understanding of how to 
use and interpret the instrument with clients and research participants. In this 
psychometric synthesis, evidence of reliability and validity of the DAST-20 scores was 
aggregated in order to provide a more comprehensive summary of the psychometric 
properties of the instrument to better inform counseling professionals when using the 
DAST-20. Overall, the available evidence indicates that the DAST-20 produces reliable 
and valid scores when screening for drug abuse consequences. However, data was limited 
and future research is needed to further assess the psychometric properties of the 
instrument, including internal consistency, test-retest reliability, convergent validity, 
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diagnostic validity, and structural validity. Implications for professional counselors and 
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CHAPTER I: INTRODUCTION 
Overview 
According to the National Institute on Drug Abuse (NIDA, 2021b), a rise in the 
use of illicit drugs has been observed in the United States. Based on data collected in 
2018, the NIDA reported that 11.7% of Americans over the age of 12 years engaged in 
illicit drug use within the previous 30 days. In the past two decades, an opioid crisis has 
been reported, with a significant rise in the number of deaths related to opioid overdose 
(U.S. Department of Health and Human Services [HHS], 2018). In 2017, there were 
70,237 fatal drug overdoses in the United States (Scholl et al., 2019). Opioids contributed 
to 47,600 of those deaths. Further, the HHS reported heroin overdoses rose by 400 
percent in the previous ten years and synthetic opioid overdose contributed to a 300 
percent increase in deaths in the previous seven years. In a study examining the 
prevalence of fatal drug overdoses over a two-year period (2017-2018), a decrease in 
overall fatal opioid overdoses was reported across the United States, which coincides 
with a decrease in the prescription of opioids (Wilson et al., 2020). Although there were 
fewer overall fatal opioid overdoses, synthetic opioid-related deaths increased by almost 
10 percent over that two-year span.  
Costs associated with drug use are assessed in three categories: crime, health care, 
and productivity (NDIC, 2011). Illicit drug use costs more than 600 billion dollars 
annually in the United States (NIDA, 2021a), which included a projected 120 billion 
dollars in lost economic productivity. In 2013, prescription opioid abuse alone cost the 




Given the prevalence of drug abuse, it is increasingly important to determine 
effective screening practices, treatment procedures, and best practices among various 
populations to identify drug abuse related consequences (Kiluk et al., 2018; USDHHS, 
2018). Screening instruments are among the first steps in assessing for drug abuse and are 
vital tools used by professionals to determine whether individuals abuse drugs 
(Rasmussen, 2000). Since screening instruments are relied upon by evaluators to help 
determine if problems related to an individual’s drug use are present, it is essential the 
instruments yield valid and reliable scores. NIDA (2021b) indicated that out of the 22.7 
million individuals in the United States who required treatment for drug abuse in 2013, 
only 2.5 million received any specialized treatment. While many factors contributed to a 
lack of treatment, use of robust screening instruments could be an important initial step in 
identifying individuals for treatment. In addition to identifying individuals in need of 
treatment, screening instruments are crucial in gathering information and identifying 
problems related to drug use to ensure the most effective treatment is provided 
(Rasmussen, 2000; Skinner, 1982a). One such screening instrument that identifies 
problems related to drug abuse is the Drug Abuse Screening Test (DAST; Skinner, 
1982b).  
The DAST (Skinner, 1982b) was developed to screen for the presence of 
consequences associated with drug abuse; currently there are four forms of the DAST 
with varying numbers of items (i.e., DAST-28, DAST-20, DAST-10, DAST-A). The 
DAST items ask about an individual’s drug use and any psychosocial problems that 
resulted from drug abuse. Common psychosocial issues resulting from drug abuse include 
psychological well-being, relationship strains, professional consequences, financial 
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hardships, and legal trouble (Maly, 1993). Identifying the presence of these issues and 
examining the extent to which they affect an individual’s life is essential in the 
identification and treatment of drug abuse problems (Maly, 1993; Rasmussen, 2000). The 
data gathered about the number and severity of problems stemming from an individual’s 
drug abuse can assist clinicians and researchers in developing tailored treatment plans, as 
well as in assessing how these issues will potentially affect an individual’s recovery 
process (Rasmussen). Information should be gathered to help determine whether the 
psychosocial issue being assessed was present prior to an individual’s problem drug use 
and how the issue may impact use of drugs (Kiluk et al., 2018; Macleod, 2010; 
Rasmussen). 
The DAST was created in response to limited instruments available to screen for 
consequences of drug use and abuse (Skinner, 1982b). Much like the Michigan 
Alcoholism Screening Test (MAST; Selzer, 1968, 1971), upon which the DAST was 
based, the DAST was established due to a lack of psychometrically sound instruments to 
screen for addictions, as many of the resources available in the early 1980’s were 
nonstandardized surveys with little psychometric support.  
Statement of the Problem 
This study examined psychometric data published by numerous researchers on the 
DAST 20-item version (DAST-20; Skinner, 1982a). The various populations and settings 
used in these studies have contributed to varying reports of psychometric values of the 
DAST-20 items. These differences in findings can lead to a misunderstanding of how to 
interpret results of this instrument, which can impact the effectiveness of the DAST-20 in 
clinical and research settings (Erford, 2021). Even with similar samples, factors such as 
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researcher, settings, and procedures can lead to varying results. This can be confusing for 
clinicians and researchers looking at multiple studies with samples that closely match 
their client. Lipsey and Wilson (2001) described aggregating the data from multiple 
similar studies as “smoothing the resulting picture into a composite, much as a magazine 
picture looks more crisp and coherent at arms length than when the pixels are examined 
through a magnifying glass” (p. 167). By combining the results from all the relevant 
studies, it provides a more robust examination of the results and allows for clinicians and 
researchers to have a clearer picture of the data. 
Researchers and clinicians have the responsibility to provide services that are 
supported by empirical evidence and ethical guidelines (American Counseling 
Association [ACA], 2014). Numerous ethical concerns need to be considered by 
researchers and practitioners when choosing and using screening instruments with 
individuals. ACA outlined ethical guidelines pertaining to the psychometric properties of 
an instrument, the population for which the instrument is being used, and necessity of 
providing empirical data that support the use of an instrument. The specific relevant 
clauses follow along with commentary. 
E.6. Instrument Selection E.6.a.  Appropriateness of Instruments  
Counselors carefully consider the validity, reliability, psychometric limitations,  
and appropriateness of instruments when selecting assessments and, when  
possible, use multiple forms of assessment, data, and/or instruments in forming  
conclusions, diagnoses, or recommendations (ACA, 2014, p. 11). 
Clause E.6.a (ACA, 2014) specifically considers the importance of examining the 
psychometric properties of an instrument before using it with clients. Empirical data on 
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an instrument should also be examined to assess the appropriate use with various 
populations and settings and their implications for interpreting results. This can be 
difficult when multiple sources are reporting differing reliability and validity values for 
scores from a particular instrument (Erford et al., 2015). Since differences in study 
conditions and samples can lead to differing outcomes, a psychometric synthesis can 
provide an overall summary of the psychometric properties on an instrument, allowing 
professionals in the field to have a better understanding of appropriate use of the 
instrument (Cook et al., 1997; Erford et al., 2015; Lipsey & Wilson, 2001).  
E.8.  Multicultural Issues/ Diversity in Assessment  
Counselors select and use with caution assessment techniques normed on  
populations other than that of the client. Counselors recognize the effects of age,  
color, culture, disability, ethnic group, gender, race, language preference,  
religion, spirituality, sexual orientation, and socioeconomic status on test  
administration and interpretation, and they place test results in proper  
perspective with other relevant factors (ACA, 2014, p. 11).   
Code E.8 (ACA, 2014) emphasizes the importance of considering many 
multicultural facets when using a particular instrument and interpreting results. Varying 
study samples can influence findings on psychometric properties of an instrument and 
can make it difficult for professionals to know how to apply a client’s results (Cook et al., 
1997; Erford et al., 2015; Lipsey & Wilson, 2001).  
E.9.b. Instruments With Insufficient Empirical Data  
Counselors exercise caution when interpreting the results of instruments not  
having sufficient empirical data to support respondent results. The specific  
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purposes for the use of such instruments are stated explicitly to the examinee.  
Counselors qualify any conclusions, diagnoses, or recommendations made that  
are based on assessments or instruments with questionable validity or reliability 
(ACA, 2014, p. 12). 
A psychometric synthesis of the reported data can help summarize differences 
among research findings due to sampling differences, allowing professionals to be more 
accurate in determining when to use an instrument and how to interpret results (Cook et 
al., 1997; Erford et al., 2015; Lipsey & Wilson, 2001). 
This study will use psychometric synthesis procedures to extract all relevant data 
and analyze the aggregated data from all included studies to provide a more 
comprehensive interpretation of the psychometric properties of the DAST-20 (Erford et 
al., 2015). This process allows a more inclusive and robust examination of the data to 
inform clinicians and researchers using the DAST-20.  
Purpose of the Study 
Due to the prevalence of drug abuse and the importance of using screening 
instruments that yield valid and reliable scores to assess individuals’ drug abuse and to 
identify the need for treatment, further examination of instruments is essential. The 
purpose of this study is to provide a comprehensive analysis of the psychometric 
properties of DAST-20 by conducting a psychometric synthesis using the findings from 
the identified relevant studies. The results will provide insight into the validity and 
reliability of the DAST-20 scores and inform clinicians and researchers who use it for 
screening and research purposes by providing a more comprehensive summary of DAST-
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20 psychometric properties (e.g., internal consistency, test-retest reliability, convergent 
validity, structural validity, diagnostic validity).  
A psychometric synthesis shares many characteristics with a meta-analysis, 
however, a meta-analysis is a specific order of procedures and statistical methods that are 
used to examine the outcome of a treatment program or intervention, whereas a 
psychometric synthesis is used to examine the psychometric properties (e.g., reliability 
estimates, validity estimates, descriptive statistics) of an instrument (B. T. Erford, 
personal communication, June 25, 2021). Both provide an empirical process to examine 
the data from various studies on a shared topic of interest to produce an aggregated 
analysis of outcomes (Erford et al., 2015). As such, the results can provide a more 
comprehensive summary of the data than looking at each of the studies individually 
across various populations and study characteristics to allow professionals to make more 
informed decisions about using and interpreting the DAST-20. By examining the analysis 
of the aggregated data, researchers can identify limitations of particular studies and 
differences in conditions that may lead to varying outcomes (Cook et al., 1997; Lipsey & 
Wilson, 2001). Therefore, psychometric synthesis studies can provide clarity on why 
these differences might occur and what their implications might mean in counseling 
practice, which allow for a more unbiased view of outcomes and a more in-depth 
examination of various conditions that affect results. Further, the procedure of examining 
the aggregated data from the included studies results in a reduction in sampling error, 
which allows a more robust report of findings (Lipsey & Wilson, 2001). In this 
dissertation, an aggregated analysis of the psychometric properties of the DAST-20 will 
be reported and implications discussed.  
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There are currently four versions of the Drug Abuse Screening Test occurring in 
the literature, including the original DAST (28 items), the DAST-20 (20 items), the 
DAST-10 (10 items), and the DAST-A (a version created for use with adolescents). The 
20-item and the 10-item versions of the DAST were created after conducting an item-
analysis of the original 28-item DAST (Skinner, 1982b, 1984). A very high correlation 
was found between the DAST-20 and the original 28-item version of the DAST (r = .99) 
(Skinner, 1982b). This study specifically examined the psychometric properties of the 
DAST-20.  
In the current study, examination of the DAST and DAST-A versions of the 
instrument were eliminated because the abbreviated versions were highly correlated with 
the original 28-item version and the DAST-A was specific to only the adolescent 
population. Examination of the DAST-20 was chosen over the DAST-10 based on 
Skinner’s (1984) recommendations for the use of each version. The DAST-20 produces a 
more comprehensive evaluation of the individual’s consequences that result from drug 
abuse and has been recommended for use at “specialized assessment centres and for use 
as a research evaluation tool,” whereas the DAST-10 has been recommended for 
“screening and case finding purposes” (Skinner, 1984, p. 30). Therefore, the findings of 
this study may be more useful to individuals using the DAST in both clinical and 
research settings. Further studies should be completed on the other forms of the DAST 
instrument in the future.  
Research Questions 
 Three research questions form the basis of this study: 
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1. What are the aggregated psychometric properties of the DAST-20 across published 
studies (i.e., internal consistency, test-retest reliability, diagnostic validity, internal 
structural validity, external convergent validity)? 
2. What are the mean scores and standard deviations of the DAST-20 in nonclinical 
samples across published studies? 
3. Are there significant differences in the psychometric properties of the DAST-20 
among various sample characteristics (e.g., gender)? 
Theoretical Orientation to the Study 
 As previously stated, the DAST (Skinner, 1982b) measures the presence of 
consequences related to an individual’s drug use. Impaired functioning theory posits that 
drug abuse has a negative impact on an individual’s functioning, which leads to issues in 
various aspects of life (Newcomb & Bentler, 1988). Further, impaired functioning theory 
provides a framework for categorizing consequences of drug abuse into physical, 
emotional, and psychological domains. Impairment in any of these domains can lead to 
problems coping with life’s stressors and completing a number of daily tasks. This theory 
supports the use of the DAST to measure consequences related to an individual’s drug 
use and the items that are included on the DAST. The 20 items on the DAST-20 inquire 
about one’s drug use and related consequences concerning physical health, relationships, 
and functioning at work (Skinner, 1982b). Impaired functioning theory will be discussed 
in further detail in Chapter 2. 
Significance of the Study 
This study provides an integrated analysis of the psychometric properties of the 
20-item version of the DAST, including internal consistency and test-retest reliability, 
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diagnostic validity, internal structural validity, external convergent validity, and 
nonclinical sample means and standard deviations. The analysis of these psychometric 
properties will provide professionals with a more comprehensive understanding of the 
instrument, which can be used to guide their work with clients (Erford et al., 2015). More 
specifically, professionals will have better insight when using this instrument with their 
clients, of implications when interpreting results, and applying this information to create 
treatment plans with clients. At a broader level, integrative syntheses can have an impact 
on policy and best practices due to a more robust examination of results (Lipsey & 
Wilson, 2001). 
Summary of Methodology 
In the current study, a psychometric synthesis process will be conducted to 
examine psychometric findings on the 20-item version of the Drug Abuse Screening Test 
(DAST-20; Skinner, 1982a) since 1982. A psychometric synthesis was chosen as the 
methodology for this study because it allows for the examination of all available data on 
the psychometric properties of an instrument, creating an aggregated summary of the 
reliability and validity (Erford et al., 2015). The process of a psychometric synthesis 
involves collecting all possible data from studies examining a common research question 
that meet the established criteria included in the study and using particular statistical 
procedures to aggregate and summarize these findings. The procedure used in this study 
was outlined by Erford et al. (2015) in a synthesis that examined the psychometric 
properties of the Beck Depression Inventory – Second Edition (BDI-II). This procedure 
includes establishing criteria for article inclusion, searching for relevant articles, 
examining articles for criteria and completing the selection process, data extraction, and 
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data analysis. A more comprehensive examination of the psychometric synthesis process 
and the methodology used in this study will be provided in Chapter 3.  
Delimitations of the Study 
 One criterion required for prospective studies to be accepted in the psychometric 
synthesis was the linguistic version of the DAST-20 used in the study and the language in 
which the study was published. This criterion helped to eliminate issues with translation 
and adaptation, but it is also important to note that there are other studies published with 
different linguistic versions of the DAST-20 and potentially relevant studies published in 
other languages that could not be included in the analysis (Lipsey & Wilson, 2001). 
Further studies are needed to examine these potential studies and the instruments’ 
psychometric properties across cultures.  
 This study also only examines the DAST-20. Other versions of the DAST (i.e., 
DAST, DAST-10, DAST-A) were not included in the study. Therefore, the results of this 
study can only be applied to guide one’s use of the English version of the DAST-20. 
Similar synthesis studies are needed to examine the psychometric properties of the other 
versions of the instrument. 
 Further, the data used in this psychometric synthesis are limited by how detailed 
the researchers of the included studies were in reporting their findings. The extraction of 
data was completed by reviewing the full text version of each study and, therefore, only 
the data that was provided in the articles could be used in this analysis of the 
psychometric properties of the DAST-20.  
 It is important to note the general limitations of psychometric syntheses and the 
criticisms that have been made about the process and reporting of results (Erford et al., 
12 
 
2015; Lipsey & Wilson, 2001), which have certain potential limitations, regardless of the 
topic being studied. For example, the specific factors of the studies, such as methodology, 
population, and analysis of data may have implications for the scope of the analysis. 
Significant factors, such as study limitations, cultural implications, theoretical 
framework, and the power and quality of the study may be overlooked in the overall 
analysis.  
Key Terms 
Drug abuse – Many terms were used in the literature to refer to drug abuse (i.e., drug use, 
drug use disorder, substance abuse, substance use, etc.). For the purposes of this study, 
the term “drug abuse” will be used to refer to Skinner’s (1982a) definition of drug abuse 
as used in the DAST and its various forms: “…‘drug abuse’ refers to (1) the use of 
prescribed or over the counter drugs in excess of the directions and (2) any nonmedical 
use of drugs” (p. 4). 
Clinical sample – A sample that was selected using a specific diagnosis (e.g., substance 
use disorder) as a criterion to be included in the study. 
Nonclinical sample – A community sample in which no criterion was used for participant 
inclusion in the study. 
Summary of Chapter 1 
 Due to an increase in illicit drug use and the disparity between the proportions of 
individuals requiring treatment for drug abuse and those individuals who actually receive 
treatment (NIDA, 2018), it is essential for medical and mental health professionals to use 
psychometrically sound instruments to screen for drug abuse and related consequences 
and the information needed to accurately interpret results. The purpose of this study is to 
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analyze the psychometric properties of the DAST-20 and provide an overall summary of 
the instrument in order to give clinicians and researchers a more comprehensive 
understanding of the usefulness of the instrument. The implications of using the DAST-
20 with particular populations and for interpretation of results will be discussed. In this 
chapter, the study was introduced, and the problem, purpose, and significance of the 
current study discussed. In Chapter 2, the current literature on drug abuse and the DAST-
20 will be reviewed.  
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CHAPTER 2: REVIEW OF THE LITERATURE 
 Due to the prevalence and severity of drug abuse, it is imperative that professional 
services are available to aid individuals dealing with substance abuse problems. In order 
to provide the most effective treatment, professionals in the field need to have screening 
and diagnostic tools available that yield reliable and valid scores to correctly identify 
individuals with drug abuse. This study aims to examine one of these instruments, the 20-
item version of the Drug Abuse Screening Test (DAST-20), which examines the presence 
of consequences related to drug abuse. An overall analysis of the psychometric properties 
of the instrument will be conducted. In this chapter, relevant literature on substance 
abuse, consequences related to substance abuse, issues pertaining to causality, ethical 
considerations, theoretical orientation, and a background on the formation and initial 
examination of the psychometric properties of the DAST-20 will be reviewed. 
Substance Abuse 
 Rasmussen (2000, p. 8) defined substance abuse as “a maladaptive pattern of 
substance use that leads to clinically significant impairment or distress.” The use of 
substances can lead to various consequences that affect an individual’s social, physical, 
psychological, occupational, and legal domains (APA, 2013; Newcomb & Locke, 2005; 
Rasmussen, 2000). The American Psychiatric Association (APA, 2013) provided 
diagnostic guidelines for assessing substance use disorders. Although there are slight 
variances among classes of substances and diagnostic criteria, the main tenet that defines 
all diagnoses of a substance use disorder is the ongoing use of a substance, regardless of 
the presence of symptoms, and problems that occur associated with the individual’s use 
of the substance. According to the Diagnostic and Statistical Manual of Mental 
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Disorders, 5th edition (DSM-5; APA, 2013), there are 11 criteria used to diagnose 
substance use disorder, regardless of the illicit substance being used. These 11 criteria are 
organized in four categories: impaired control, social impairment, risky use, and 
pharmacological.  
The first category, impaired control, includes criteria one through four, which 
dictate that an individual may increase dosage or use the substance for an extended 
amount of time, display an inability to reduce dosage or frequency of use, devote a 
significant portion of their time to either procuring, using, or recuperating from the 
substance, and exhibit cravings for the substance. The second category, social 
impairment, consists of criteria five through seven, which indicate that the individual is 
experiencing decreased functioning in required tasks at work, school, or home, relational 
issues, and a decrease in participation of social activities.  
Risky use is categorized by criteria eight and nine, which assess an individual’s 
substance use regardless of potential physical harm. Criterion eight indicates that an 
individual is repeatedly using substances in dangerous settings, whereas criterion nine 
indicates continual use of the substance regardless of physical or psychological 
consequences. Lastly, the pharmacological category includes criteria 10 and 11, which 
signify problems of tolerance and withdrawal to the substance.  
Substance use disorder exists along a continuum ranging from mild to severe. 
These disorder levels are determined by the number of criteria evident in relation to an 
individual’s substance use. The DSM-5 standards for determining which severity 
category (mild, moderate, or severe) an individual’s substance use disorder falls under is 
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defined as two to three criteria present, four to five criteria present, and six or more 
criteria present, respectively (APA, 2013). 
Consequences Related to Drug Use 
 The DAST-20 is focused specifically on measuring the presence of consequences 
as an outcome of drug abuse. This is one method for determining the degree of severity 
the drug addiction has on an individual’s life. Research has provided evidence of 
significant relationships between drug abuse and the consequences an individual 
experiences. Consequences related to drug abuse can occur in various areas of an 
individual’s life, including physical health, psychological, and social issues, all of which 
can be classified as short-term or long-term effects (Newcomb & Locke, 2005). A more 
thorough understanding of the potential consequences of an individual’s drug abuse can 
allow professionals to provide a more effective treatment plan when working with a 
client (Skinner, 1982a). 
Physical Health-related Consequences 
 Drug abuse was linked to various physical health issues, which ranged in severity 
depending on the drug being abused and the frequency and quantity of use (Newcomb, 
1997; Rasmussen, 2000). Rasmussen categorized physical health problems resulting from 
drug abuse as gastrointestinal issues, dermatological side effects, genitourinary signs, 
neuromuscular issues, cardiovascular issues, respiratory issues, and physical trauma 
related to one’s drug use. Gastrointestinal issues can range from mild side effects of a 
particular drug (e.g., nausea, constipation, diarrhea) to developing more serious 
complications such as hepatitis and cirrhosis (Lange et al., 1992; Rasmussen, 2000).  
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Depending on the drugs used and the method of ingesting drugs, individuals may 
experience dermatological issues such as increased perspiration, complexion fluctuations, 
scarring due to burns or needle marks, as well as rashes, bruises, and skin infections 
(Rasmussen, 2000). Individuals who abuse drugs are also at a higher risk of developing 
sexually transmitted diseases. Infections and a weakened immune system were also 
associated with drug abuse (Lange et al., 1992). Neuromuscular issues were associated 
with drug abuse and included problems such as “slurred speech, tremors, lack of 
coordination, poor muscle tone, extremity weakness, hyperactive reflexes, seizures, and 
coma” (Rasmussen, 2000, p. 3). Further, individuals who abuse drugs can experience side 
effects such as “chest pain, palpitations, and various cardiac dysrhythmias” and blood 
pressure, heart rate, and breathing fluctuations (Rasmussen, 2000, p. 4). It is not 
uncommon for physical trauma to occur as a result of accidents and/or altercations related 
to one’s drug abuse (Lange et al., 1992; Rasmussen, 2000).  
 The DAST-20 (Skinner, 1982a) has two items that ask about physical symptoms 
and consequences that resulted from an individual’s drug abuse. Item 17 asks “Have you 
ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs?” and 
item 18 asks individuals “Have you had medical problems as a result of your drug use 
(e.g., memory loss, hepatitis, convulsions, bleeding, etc.)?” 
Psychological Consequences 
 Several studies indicated a significant relationship between drug use and 
psychological issues (Gove et al., 1979; Newcomb & Locke, 2005; Newcomb et al., 
1999). In a study examining individuals’ drug use and psychological well-being, a 
significant positive correlation was found between the number of types of drugs an 
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individual used and their overall psychological well-being and symptoms of mental 
health issues (Gove et. al, 1979). These researchers cautioned about the inability to 
determine directionality of this correlation, however, and posited a theory that an 
individual’s psychological issues contributed to the decision to use drugs as an attempt to 
increase overall psychological well-being.  
Newcomb et al. (1999) found evidence of a reciprocal relationship between drug 
abuse and psychological well-being when conducting a four-year longitudinal study of a 
community sample of 470 adults, measuring participants’ overall psychological well-
being and drug use status. These researchers found significant positive correlations 
between drug abuse and “dysphoria, agitation, psychoticism, and disorganized thinking” 
(p. 421). However, there was evidence of both drug abuse following psychological 
problems, as well as preceding psychological problems. Dysphoria reported at the initial 
survey was correlated with an increase in alcohol consumption four years later. Thoughts 
of suicide and lower self-esteem present initially was positively correlated with drug use 
four years later. Further, drug abuse at the initial survey was correlated with increased 
anxiety and hostility and decreased feelings of purpose four years later. Marijuana use at 
the initial survey was associated with an increase in suicidal ideation and psychoticism 
four years later and cocaine use initially was associated with an increase in hostility.    
Social Consequences 
 Interpersonal issues were associated with drug abuse, including relationship 
strains with family members and friends (Rasmussen, 2000). It is not uncommon for drug 
abuse to cause issues within a family, including parenting issues (Newcomb & Locke, 
2005; Rasmussen, 2000; Visser, 1991), separation or divorce (Rasmussen, 2000; Visser, 
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1991), as well as physical and emotional neglect of family members (Visser, 1991). 
Visser stated that a parent with drug abuse problems can have difficulty providing what a 
child needs physically and emotionally, which can lead to neglect and abuse. In a study 
examining the correlation between parental drug abuse and the occurrence of child abuse, 
researchers found the rate of child abuse more than doubled among families where at 
least one parent had a drug abuse problem (Walsh et al., 2003). Substance abuse also was 
associated with a decrease in the overall functioning and satisfaction of a 
marriage/relationship (Newcomb, 1997). Friendships can also deteriorate (Rasmussen, 
2000). The impact of substance abuse on relationships can result in a loss of a social 
support network. According to Visser (1991), consequences of drug abuse within a 
family, including dysfunction among family members and feelings of guilt and shame 
about the drug abuse, can lead to isolation from not only those close to the family, but 
from society in general. 
The DAST-20 (Skinner, 1982a) includes items that inquire about the social 
consequences of drug abuse. Items 8-11 address the effects of drug use on relationships 
with family and friends. Item 8 states, “does your spouse (or parents) ever complain 
about your involvement with drugs?;” item 9 asks “has your drug abuse created problems 
between you and your spouse or your parents?;” and item 11 asks “have you neglected 
your family because of your use of drugs?” 
 Drug abuse can also have a negative impact on an individual’s career (Newcomb, 
1997; Newcomb & Locke, 2005; Rasmussen, 2000). Researchers found that drug abuse is 
associated with impaired functioning at work, an inability to focus on tasks, a rise in 
absenteeism, an increase in errors, lapses in judgement, unnecessary risk-taking, and 
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negligent actions (Rasmussen, 2000). Due to these issues, it is not uncommon for 
individuals to experience job loss or repeated changes in employment (Galaif et al., 2001; 
Rasmussen, 2000). In a study examining the relationship between drug abuse and job 
adjustment among a community sample of adults, Galaif et al. found a significant 
correlation between occupational consequences and drug abuse. More specifically, 
individuals who reported issues with drug abuse had an increased chance of experiencing 
issues such as unpredictable employment and lowered overall work satisfaction. 
 There are two items on the DAST-20 that inquire about job/work consequences 
resulting from drug abuse. Item 12 states, “have you been in trouble at work (or school) 
because of drug abuse?” and item 13 asks “have you lost your job because of drug 
abuse?” (Skinner, 1982a). 
Legal issues are another commonly reported consequence of drug abuse. Thus, 
legal issues were included in the DSM-5 as one criterion used to assess the presence of 
drug abuse (APA, 2013; Newcomb & Locke, 2005; Rasmussen, 2000). At the end of 
2016, approximately 15% of inmates in state-level correctional facilities were charged 
with a drug-related crime (Bronson & Carson, 2019). Items 14 through 16 on the DAST-
20 assess the presence or absence of legal consequences experienced due to drug abuse: 
“have you gotten into fights when under the influence of drugs?;” “have you engaged in 
illegal activities in order to obtain drugs?;” and “have you been arrested for possession of 
illegal drugs?;” respectively (Skinner, 1982a). The remaining seven items on the DAST-
20 ask the individual about drug use activity and frequency (items 1 through 5), as well 
as drug treatment history (items 19 and 20; Skinner, 1982a). 
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It is important to note that instruments which examine the presence and severity 
of consequences due to drug abuse do not necessarily identify which consequences are a 
direct result of the drug abuse (Kiluk et al., 2018; Macleod, 2010). In a study that 
examined drug abuse and work adjustment, Galaif et al. (2001) found drug abuse not only 
had a significant impact on overall work adjustment, but individuals who had 
experienced unpredictable employment status earlier in life were more likely to report 
drug abuse four years later. Macleod (2010) argued that when considering environmental 
factors and adversity, professionals in the field need to  
distinguish between (a) situations where drug use mediates the association 
between disadvantage and psychosocial harm, (b) situations where drug use  
causes harm irrespective of any association with disadvantage, and (c) situations  
where drug use is mainly a marker of a toxic environment that causes harm  
through other pathways.” (p. 25) 
Similarly, when discussing the Addiction Severity Index (ASI), another 
assessment that measures an individual’s addiction severity within different psychosocial 
categories, Kiluk et al. (2018) indicated that although the severity of issues may be 
measured, it does not necessarily indicate issues and severity due to one’s addiction. For 
example, the issues present may be a result of substance abuse and present prior to 
substance use. In this case, the problem contributed to one’s substance abuse, and the 
substance abuse may or may not continue to impact problem severity. Newcomb (1997) 
examined many facets of the consequences associated with drug abuse and argued that 
while drug abuse likely led to the deterioration of relationship quality, poor relationship 
quality may also impact drug abuse.  
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Although consequences may be associated with the presence of drug use, it is 
important not to assume that the relationship between the factors are causal or 
unidirectional. Therefore, ethical obligations and best practices require further data 
collection to examine the relationship between drug use and problems present. Skinner 
(1982a) included the criterion of drug use in each item of the DAST-20 instrument. Each 
item asks about the presence of a consequence in relation to an individual’s use of drugs. 
For example, item 10 asks the individual to answer in yes or no format the question, 
“Have you lost friends because of your use of drugs?” This criterion may aid in the 
identification of issues that are a consequence of substance abuse based on the 
individual’s perception of their issues. 
Impaired Functioning Theory 
 Impaired functioning theory is based on the premise that drug abuse causes 
physical, psychological, and emotional consequences in an individual’s life (Newcomb & 
Bentler, 1988). The negative consequences “can result from the psychoactive effects of 
the drug on cognitive, affective, and behavioral processes…[or]…arise from the 
deleterious effects due to the mode of ingestion and/or the metabolizing of the substance 
by the body on the physical level” (p. 26). The impaired functioning theory postulated 
that the psychoactive effects on an individual’s various processes can lead to alteration of 
one’s insight, awareness, ability to focus and process information, and/or emotional 
expression. Due to the differences in functioning among the various domains, an 
individual may have difficulty performing daily activities and coping with life’s stressors. 
The tenets of the impaired functioning theory provide a supportive framework for the 
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consequences of drug abuse across three domains of an individual’s life: physical health, 
psychological well-being, and social impairment. 
Assessment and Screening Instruments 
 Assessment is a critical process in clinical and research practices. Assessment is 
necessary to ensure clients are accurately diagnosed and receive the care and resources 
needed (Erford, 2021). Screening, typically one of the first steps in assessment, is used 
with the goal of identifying the need for further assessment. Screening instruments are 
not intended for diagnostic purposes, but instead identify the potential need for a more 
comprehensive, diagnostic assessment (Erford, 2021; U.S. Preventative Services Task 
Force [USPSTF], 2020). Although screening instruments are not robust enough to be 
considered appropriate for diagnostic purposes, it is important that they yield valid and 
reliable scores to ensure that the proper decision is being made as to whether or not an 
individual is referred for further assessment. Screening instruments that yield valid and 
reliable scores help ensure that false negative results do not occur, reducing the risk that 
an individual who should be referred for further diagnostic assessment does not get 
overlooked (Erford, 2021).  
 Screening instruments that assess drug abuse are classified as either logically 
derived instruments or empirically derived instruments (Piazza et al., 2000). Logically 
derived instruments are direct in what is being measured and tend to demonstrate high 
content validity, but are at higher risk for response bias and, therefore, false negatives. 
Empirically derived instruments that assess drug abuse include items that are not 
necessarily directly asking about drug abuse, however, have high predictive validity of 
the presence of drug abuse. This type of drug abuse screening instrument may produce 
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less risk of response bias; however, it is limited in what information can be gleaned about 
an individual’s drug abuse. 
 Multiple screening instruments exist to assess individuals for the potential 
presence of drug abuse, related consequences, or severity of use (USPSTF, 2020). Given 
the availability of screening instruments assessing drug abuse, clinicians and researchers 
have multiple considerations when choosing to use a specific assessment, such as client 
age, length of the assessment, assessment delivery format, pertinent characteristics of a 
client, and associated financial costs (NIDA, 2018; USPSTF, 2020). 
Drug Abuse Screening Test (DAST) 
The Drug Abuse Screening Test (DAST; Skinner, 1982a) is a 28-item self-report 
instrument developed to determine the severity of the impact of drug abuse on an 
individual’s life. The DAST is a logically derived instrument intended to provide a means 
for screening for drug abuse as well as researching and evaluating treatment. Skinner 
indicated that the DAST can be used in conjunction with other data collection methods to 
gain more insight into an individual’s issues related to their drug abuse and to measure 
the effects of treatment. 
The DAST is given by means of self-administration or interview (Skinner, 1982a, 
1984). Self-administration allows delivery to multiple individuals in an efficient manner. 
Skinner (1982a) suggested the self-administration method may help lessen bias and 
under-reporting of issues to allow more valid responses. However, an interview format is 
recommended for individuals who may have difficulty comprehending the material. 
The 28 items require the responder to answer in a yes or no format for each 
question (Skinner, 1982a). The individual taking the assessment is instructed to answer 
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the questions based on drug use over the course of the past 12 months with the exception 
of alcohol use. Skinner (1982a) defined drug abuse in the questionnaire instructions as  
(1) the use of prescribed or over the counter drugs in excess of the directions and 
(2) any non-medical use of drugs. The various classes of drugs may include: 
cannabis (e.g. marijuana, hash), solvents, tranquillizers (e.g. Valium), 
barbiturates, cocaine, stimulants (e.g. speed), hallucinogens (e.g. LSD) or 
narcotics (e.g. heroin) (p. 1). 
 Since the development of the initial 28-item version of the DAST, three additional 
formats have been developed, including DAST-20, DAST-10, and DAST-A. The DAST-
20 and the DAST-10 are both shorter versions of the DAST comprised of 20 and 10 
items, respectively. The DAST-A was created for use with adolescents. 
DAST-20 
The DAST-20 version contains 20 yes or no questions about an individual’s drug 
abuse and the number of consequences associated with drug abuse (Skinner, 1982a). The 
questions assess presence of consequences in various aspects of an individual’s life, 
including issues with friends, family, work, incarceration, and physical and medical 
implications. The DAST-20 is recommended for use in clinical settings and for research 
evaluation as it provides more information about an individual’s consequences related to 
drug abuse than the DAST-10 (Skinner, 1984). 
The DAST-20 is scored by applying values of either 1 or 0 based on whether the 
individual responded with yes or no for a particular question (Skinner, 1982a). For all but 
two questions, a response of “yes” results in a score of 1, indicating an issue associated 
with substance abuse is present and a response of “no” results in a score of 0. Items 4 
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(“Can you get through the week without using drugs?”) and 5 (“Are you always able to 
stop using drugs when you want to?”) have reverse scoring procedures, as a “yes” 
response indicates less negative impact of drug abuse. The score can range from 0 to 20, 
which represents a range of severity of consequences associated with an individual’s 
substance abuse; a lower score indicates less severity of consequences associated with 
substance abuse with a score of 0 signifying that there were no consequences associated 
with substance abuse reported by an individual. 
Additional Forms of the DAST 
 The DAST was also reduced to 10 yes or no items (DAST-10). Skinner (1984) 
recommended the DAST-10 be used to screen for drug abuse consequences since it does 
not provide as much information about an individual’s consequences. Still, scores on the 
DAST-10 were found to have psychometrically sound characteristics. 
The DAST-A is an adolescent version that includes items similar to the DAST-20, 
but the 20 questions focus on relationships with parents when assessing relationship 
consequences and on school when assessing an adolescent’s ability to function. In 
contrast, the DAST-20 includes relationships with spouses/partners and occupational 
consequences (Skinner, 1982b). The instrument is scored in the same manner as the 
DAST-20. Values of either 0 or 1 are added together based on whether the individual 
responded with “yes” or “no” for a particular question. For all but two questions, a 
response of “yes” results in a score of 1, indicating a consequence associated with 
substance abuse is present and a response of “no” results in a score of 0. As with the 
DAST-20, items 4 (“Can you get through the week without using drugs?”) and 5 (“Are 
you always able to stop using drugs when you want to?”) have reverse scoring 
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procedures, as a “yes” response indicates less negative impact of drug abuse. The score 
can range from 0 to 20, which represents a range of severity of consequences associated 
with an individual’s substance abuse; a lower score indicates less severity of 
consequences associated with substance abuse with a score of 0 signifying that there were 
no consequences associated with substance abuse reported by an individual. 
The DAST-20 was chosen for the current study due to the various uses and 
settings recommended by Skinner (1982a) when compared to the DAST-10 and for the 
broader demographics with which it is commonly used, compared to the adolescent 
version of the instrument. 
DAST Formation 
The DAST (Skinner, 1982b) was developed based on the Michigan Alcoholism 
Screening Test (MAST; Selzer, 1971). The MAST was developed to address the absence 
of a standardized instrument to identify the presence of alcoholism. Selzer found that the 
instruments available were based on varying definitions of alcoholism and alcohol abuse 
and relied on poorly defined categorizations of individuals’ alcohol consumption as 
opposed to the consequences an individual is experiencing due to their alcohol use. For 
example, some definitions of alcoholism included invalid observations of one’s 
appearance and hygiene (Selzer, 1968). Discordant and invalid definitions of alcoholism 
made it difficult to identify individuals with an actual alcohol use problem. A 
standardized instrument that could produce valid and reliable scores was needed to help 
identify individuals with alcoholism (Selzer, 1968, 1971). 
The MAST (Selzer, 1971) is comprised of 25 yes or no questions that inquire 
about an individual’s consequences associated with use of alcohol related to relationships 
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with family and friends, work issues, health problems, legal issues, and psychological 
consequences. Scoring of the MAST is based on the magnitude of each item in 
addressing alcoholism (Selzer, 1968). A cumulative value of four or more points is 
considered a positive screening for alcoholism. Studies have indicated that the MAST is a 
psychometrically sound instrument for screening purposes (Skinner, 1984). A synthesis 
of the psychometric properties of the MAST scores revealed an aggregated internal 
consistency coefficient of .84, indicating the MAST to yield reliable scores for screening 
for alcohol-related issues; however, this value fell short of the recommended coefficient 
of .90 for diagnostic purposes (Minnich et al., 2018).   
Consequences related to alcohol abuse can be compared to consequences an 
individual can experience from drug abuse (Skinner, 1984). Therefore, Skinner (1982b) 
created the DAST based on the MAST to provide an instrument that could screen for 
drug abuse consequences. 
Initial Evaluation of the DAST-20 
The initial evaluation of the score validity and reliability of the DAST yielded 
positive results for all forms of the instrument (Skinner, 1982b). Skinner examined the 
psychometric properties of the original 28-item version of the DAST in a study that 
sampled 223 individuals in an addiction treatment program and DAST scores had high 
internal consistency (KR-20 = .92).  
 Scores from the DAST-20 were highly correlated with the 28-item DAST (r = 
.99) and DAST-10 (r = .98) among the total sample (Skinner, 1984). The DAST-28 and 
DAST-10 scores correlated r = .97. High internal consistency was reported for the 
DAST-20 scores (KR-20 = .95) for the entire sample (including substance abuse of drugs 
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and/or alcohol) and for a subgroup that did not include participants who reported only 
abuse of alcohol (i.e., drug use only; KR-20 = .86; Skinner, 1982b). 
An evaluation of the DAST-A was conducted by Martino et al. (2000) with 
adolescents in an inpatient facility. The DAST-A scores were significantly positively 
correlated with five related instruments. The researchers also found that the DAST-A 
scores had adequate internal consistency (KR-20 = .91) and test-retest reliability (r = .89). 
Advantages and Limitations of the DAST 
Skinner (1982a) identified numerous advantages and limitations of using the 
DAST to assess an individuals’ level of issues associated with substance abuse. The 
DAST is a cost-efficient (i.e., free) means of collecting a measure of drug abuse impact 
that can be administered individually or in a group format (Skinner, 1982a, 1984). The 
DAST not only provides an overall score indicating the level of consequences associated 
with drug abuse, but also can be used as a foundation to gain further data and information 
on the identified areas most affected by drug abuse. The DAST can be used in 
conjunction with other instruments to validate findings. However, the DAST is 
susceptible to participants underreporting their substance abuse. Also, the DAST is not a 
comprehensive assessment of all aspects of an individual’s substance abuse and should be 
used in conjunction with other means of collecting data.  
Psychometric Properties of the DAST-20 Scores 
Since the initial study on the psychometric properties of the DAST-20 scores 
(Skinner, 1982b), numerous studies reported quantitative data on the reliability and 
validity of DAST-20 scores among various populations (Cassidy et al., 2008; Cocco & 
Carey, 1998; Grekin et al., 2010; Salehi et al., 2012). Due to varying research conditions, 
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limitations, and populations, differences in psychometric properties of the DAST-20 have 
been reported, which can have a significant effect on a professional’s ability to interpret 
and apply DAST-20 scores in treatment and research (Erford et al., 2010; Lipsey & 
Wilson, 2001). A preliminary review of these findings is summarized below. 
Reliability 
Numerous studies reported internal consistency values for the DAST-20 scores 
(Aubry et al., 2011; Bliss et al., 2008; Boyd et al., 2009; Brocato & Wagner, 2008; 
Burnett et al., 2013; Cassidy et al., 2008; Fineran et al., 2010; Forbey & Ben-Porath, 
2008; Forbey et al. 2011; Gerlock, 2004; Kaslow et al., 2006; Kimbrel et al., 2011; 
Murphy et al., 2007; Nordfjaern, 2013; Perepletchikova et al., 2012; Reviere et al., 2007; 
Rosenkranz et al., 2012; Sabato et al., 2013; Sullivan et al., 2009; Ting et al., 2009). 
Among these studies, the reported reliability value (KR-20) ranged from 0.71 
(Rosenkranz et al., 2012) to 0.998 (Cassidy et al., 2008). Erford (2021) recommended 
internal consistency values of at least .80 to consider scores from an instrument 
acceptable for screening purposes and at least .90 for use as a diagnostic tool. Such large 
variances in reported internal consistency values can affect best practice across diverse 
populations. 
Validity 
Data on the validity of the DAST-20 scores were reported in numerous studies 
over the last few decades. Convergent validity was demonstrated with scores from the 
DAST-20 and similar instruments, including the MMPI-2 Restructured Clinical Scales 
(Forbey & Ben-Porath, 2008), the Externalizing Inventory (100-item; Hall et al., 2007), 
the MAST (Marshall & Marshall, 2006), the Marijuana Screening Inventory (MSI-X; 
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Alexander & Leung, 2006), the Research Institute on Addictions Self-Inventory (Shuggi 
et al., 2006), the NEO-PI-R (Conner et al., 2004), the CAGE and the SASSI-2 (Teslak, 
2000), and the ADS and MAST (Gavin et al., 1989). Further analysis and discussion of 
findings in regard to convergent validity will be provided in the Results and Discussion 
sections of this study. 
Multiple studies reported data on the diagnostic validity (decision reliability) of 
the DAST-20 scores with varying findings on the sensitivity, specificity, positive 
predictive power, and negative predictive power. Multiple cut-off scores have been 
recommended across these studies. The data reported from these studies on the criterion 
validity of the DAST-20 will be summarized in the Results chapter of this study. 
Ethical Considerations When Using Screening Instruments 
Counselors and researchers must take numerous ethical considerations into 
account when choosing instruments to use with clients and research participants. 
Specifically, the American Counseling Association (ACA, 2014) outlined ethical 
standards pertaining to the psychometric properties of an instrument, the population in 
which instruments are used, and empirical data that support the use of an instrument. 
These specific clauses include E.6.a, E.8, and E.9.b. 
 ACA’s Code of Ethics (2014) supports the need for various methods of data 
collection when working with clients and research participants in order to gather a more 
complex understanding of an individual’s drug use and psychosocial factors. When using 
instruments, professionals also need to be aware of any multicultural considerations that 
may affect score reliability and validity of an instrument and how results are interpreted. 
For example, researchers reported differences between the consequences experienced by 
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men and women due to substance abuse (Newcomb, 1997; Plant et al., 2002; Robbins, 
1989). Robbins found women were more likely to report consequences of depression, 
trust issues, and feeling distressed, whereas men were more likely to report issues related 
to school, work, finances, legal problems, driving under the influence, and urgent health 
issues. The reported differences between men and women were attributed to men’s higher 
occurrence of substance abuse than women. Women who reported abusing marijuana and 
cocaine were also more likely to report relational consequences such as engaging in 
altercations and arguments. In contrast, a study conducted using a cross-sectional survey 
of individuals in the United Kingdom found that women were more likely than men to 
report negative consequences due to substance abuse (Plant et al.). Although various 
studies reported on differences in experiences among men and women, these differences 
are not always considered by clinicians and researchers (Newcomb).  
Another example of multicultural factors that could have significant impact on 
outcomes is age (Newcomb, 1997). Newcomb made the argument that different 
consequences of drug abuse may be present depending on an individual’s age and the 
tasks that occur during that particular life stage. 
Issues with Application of Individual Study Results 
 It is not uncommon for researchers conducting similar studies to report 
contradicting results leading to differing conclusions (Erford et al., 2015; Lipsey & 
Wilson, 2001). This can make it difficult for professionals to know how to implement the 
conclusions from the various studies when working with clients. The differences in 
findings among the various studies can be attributed to the specific samples, researchers, 
methods, and conditions of each individual study. Many of the samples in the studies that 
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reported data on the psychometric properties of the DAST-20 are very specific and not as 
generalizable to the population of clients of mental health professionals. Some examples 
of these samples include patients with burn injuries (Salehi et al., 2012), individuals with 
a mental disorder (Cocco & Carey, 1998), women who recently gave birth (Grekin et al., 
2010), and individuals with first-episode psychosis (Cassidy et al., 2008). Further, some 
studies used clinical samples while others used nonclinical samples, and even different 
diagnostic criteria (e.g., DSM, ICD, author created) were used to assess the psychometric 
properties of the DAST-20. Multiple studies reported issues of generalizability of results 
in the discussion of study limitations (e.g., Alexander & Leung, 2006; Grekin et al., 
2010). 
 Much like a meta-analysis, a psychometric synthesis can allow for a more 
comprehensive examination of a topic, which better informs professionals making 
decisions based on the available literature (Erford et al., 2015; Lipsey & Wilson, 2001). 
Lipsey and Wilson explained the benefits of meta-analysis by comparing it to looking at 
individual pixels versus looking at the overall picture from a distance. Aggregating the 
data from all the studies of varying samples, methods, and conditions allows for 
“smoothing the resulting picture into a composite, much as a magazine picture looks 
more crisp and coherent at arms length than when the pixels are examined through a 
magnifying glass” (Lipsey & Wilson, 2001, p. 167).   
Chapter 2 Summary 
 Most studies of the psychometric properties of the DAST-20 concluded the 
instrument yielded reliable and valid scores among various populations. However, 
multiple optimal cutoff scores were reported, and findings of various factor analyses and 
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diagnostic validity studies (sensitivity, specificity), and internal consistency values 
differed. Many of the studies used homogeneous samples in a specific setting, which 
limit the generalizability of the findings. The purpose of the current study is to examine 
the findings from all of the identified studies and analyze the aggregated data to provide 
insight on the overall psychometric properties of the DAST-20 scores and then discuss 
implications for researchers and clinicians using the DAST-20 with various populations.  
35 
 
CHAPTER 3: METHODOLOGY 
Research Design 
 Psychometric synthesis procedures outlined by Erford et al. (2015) were used to 
quantitatively examine the psychometric properties of the DAST-20 (Skinner, 1982a). 
Although the research design is modeled on the study named above (Erford et al., 2015), 
the correct classification of this research design is called a psychometric synthesis. A 
psychometric synthesis has many procedural characteristics in common with a meta-
analysis. However, in recent years, very specific procedures define a meta-analysis 
(Lipsey & Wilson, 2001). Therefore, the article this study models is more correctly 
classified as a psychometric synthesis. The procedures in a psychometric synthesis are 
included in a meta-analysis, however not all procedures of a meta-analysis are included in 
a psychometric synthesis.  
A synthesis is conducted by following specific steps to examine the findings of 
empirical studies that have produced results on a common subject of research (Erford et 
al., 2015). This research design involves collecting all possible data from studies 
examining a common research question that meet the established criteria of the study and 
using particular statistical procedures to summarize these findings. This includes 
establishing criteria for article inclusion, searching for relevant articles, examining 
articles for criteria and completing the selection process, data extraction, and data 
analysis. This psychometric synthesis will examine the reliability and validity of the 
DAST-20 scores, combining the results of numerous articles that report data for the 
instrument. After selecting the studies used in the psychometric synthesis, analyses were 
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conducted on the reported results to produce a more comprehensive understanding of 
outcomes. 
Procedure 
 The procedure utilized in this study was outlined by Erford et al. (2015) in a 
psychometric synthesis study that examined the psychometric properties of the Beck 
Depression Inventory – Second Edition (BDI-II; Beck et al., 1996). The procedure 
includes specific methods for searching for and identifying potential articles for inclusion 
in the study, accepting or rejecting these studies, extracting data, and analyzing the data. 
These procedures are described in detail below.  
Article Selection and Criteria 
 A search for sources that contained psychometric data on the DAST-20 was 
conducted. The search for relevant sources included published journal articles as well as 
unpublished documents, such as dissertations, theses, and other unpublished sources that 
were available through research databases, including all possible sources of psychometric 
data on the DAST-20 into the study, reduced potential publication bias (Erford et al., 
2015). 
Lipsey and Wilson (2001) identified several areas of eligibility criteria that apply 
to most meta-analyses, including “distinguishing features, research respondents, key 
variables, research methods, cultural and linguistic range, time frame, and publication 
type” (pp. 16-17). Candidate articles selected for inclusion in the current study were 
published or available between 1982 and 2014 (the year this study was started). For the 
purposes of this study, more current studies will not be added, however, any articles 
published between 2015 and 2021 will be included before this manuscript is submitted 
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for publication. Selection for inclusion also required the use of the English version of the 
shortened 20-item form of the DAST (DAST-20) and at least one psychometric property 
of the DAST-20 reported, including internal consistency, test-retest reliability, 
convergent validity, structural validity, diagnostic validity, and descriptive statistics. 
Studies that reported means or standard deviations of the DAST scores were only 
included if data were collected from nonclinical samples. 
Search Procedures 
 The initial search for included sources was conducted through research databases, 
including PsychINFO, ERIC, Academic Search Premier, MEDLINE, and Cochrane 
Database of Systematic Reviews using the search text “Drug Abuse Screening Test” from 
dates 1982 (the year the DAST was published) to 2014. To ensure all relevant data was 
included in the analysis, a second search was conducted of the reference list of any source 
that reported psychometric data. This redundant procedure was undertaken to obtain 
potential sources that were not included in the original electronic search. Also, to make 
sure data from a particular study was only used once in the data analysis, the list of 
articles was searched for repeated occurrences. For example, dissertations and articles 
resulting from a dissertation were analyzed for relevant psychometric data, but the 
sample result was only used once to maintain independence of results. Once all the 
articles were obtained through the multi-step search process, the selection process was 
started. 
Selection Process 
The full text version of all articles identified by the search process were obtained 
and numbered to organize selection procedures. The selection process was independently 
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conducted by the author and two additional research assistants in order to ensure accurate 
inclusion and rejection decisions of each article. The inclusion criteria listed above were 
used to evaluate each article to determine whether or not the study provided usable data 
for analysis. A further description of the psychometric variables of interest is provided 
below. Each researcher inserted an independent decision for inclusion of each article in a 
chart. If the decision was to accept an article for inclusion in the study, a short description 
of the data of interest was included in the chart. A final compiled chart was completed, 
listing each researcher’s decision for inclusion of each article. An inter-rater agreement 
percentage was calculated at 95%. Ultimately, the decision to include or exclude articles 
that were not agreed upon by the selectors was deferred to Dr. Erford, who has completed 
many psychometric syntheses and has published on the research design.  
After the selection process was finalized, data was extracted from all articles 
accepted for inclusion. To ensure that aggregated data from a particular study was only 
represented in the data analysis once, duplicative articles were rejected and dissertations 
and articles using the same sample were used only once so the resulting data would 
maintain independence. 
Psychometric Variables Analyzed 
The psychometric variables of interest for the analysis of this study included data 
on internal consistency, test-retest reliability, convergent validity, structural validity, 
diagnostic validity, and the means and standard deviations of nonclinical samples. 
Reliability statistics of interest included internal consistency coefficients and test-retest 
reliability data. Internal consistency refers to how well a set of items on an assessment 
inter-correlate or hang together (Erford, 2021). Because responses to the DAST-20 are 
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dichotomous (yes-no), Kuder-Richardson formula 20 (KR-20) was the most common 
statistic used to examine the internal consistency of the DAST-20. Test-retest reliability 
statistics represent the degree of consistency of an individual’s responses on an 
instrument when administered twice. Pearson r is the statistic most commonly used to 
examine test-retest reliability of the DAST-20. The time lapsed between the first and 
second administrations of the DAST-20 was noted for each eligible study. 
Multiple validity statistics were examined to determine the ability of the DAST-
20 in accurately measuring the construct of interest (Erford, 2021). Validity measures of 
interest in the current psychometric synthesis included measures of convergent and 
diagnostic validity (i.e., overall accuracy, sensitivity, specificity, positive predictive 
power, negative predictive power), and structural validity (i.e., confirmatory factor 
analysis, exploratory factor analysis). Construct validity refers to the ability of an 
instrument to accurately measure the construct of interest, such as by providing statistical 
evidence on convergent and discriminant validity. In the current study, articles were 
screened for convergent validity statistics on the DAST-20. Convergent validity helps to 
determine whether an instrument demonstrates adequate construct validity by statistically 
comparing it with scores on other instruments measuring the same or a very similar 
construct. If a high positive correlation is found between the two instruments, it is an 
indication that the instrument under question demonstrates construct validity. In the 
current psychometric synthesis study, Pearson r was normally the statistic used to 
examine convergent validity. 
Diagnostic validity refers to the ability of an instrument to accurately determine 
the presence or absence of a specific diagnosis or condition. In order to determine the 
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diagnostic validity of an instrument, the scores of the instrument are compared to the 
findings of a clinical evaluation or diagnosis of an individual completed by a mental 
health professional (Erford, 2021). Although the DAST-20 is a screening instrument and 
is not intended as a diagnostic assessment, it is still important that the instrument 
accurately identifies individuals who most likely have an issue with drug abuse to allow 
appropriate and timely referral for further evaluation, as needed. In the initial 
examination of the DAST-20, Skinner (1982b) recommended a cutoff score of six for 
screening purposes. Data of interest on the diagnostic validity of the DAST-20 included 
the percent of individuals correctly classified overall by the instrument, specificity 
values, sensitivity values, positive predictive values, and negative predictive values. 
The test cutoff score and the criterion cutoff determined for the clinical evaluation 
are used to examine these various indices of diagnostic validity (Erford, 2021). These 
indices include sensitivity, specificity, positive predictive power, and negative predictive 
power. Sensitivity refers to the ratio of true positives identified by the instrument cutoff 
(individuals correctly identified to have a problem with drug abuse) out of all the 
individuals identified to have a problem with drug abuse by the criterion cutoff 
determined by the clinical evaluator (true positives plus false negatives of the 
instrument). Specificity refers to the ratio of true negatives identified by the instrument 
cutoff (individuals correctly identified to not have a problem with drug abuse) out of all 
the individuals who were determined not to have a problem with drug abuse by the 
criterion cutoff determined by the clinical evaluator (true negatives and false positives of 
the instrument). Positive predictive power refers to the instrument’s ability to predict the 
presence of a drug abuse problem. This statistic is determined by calculating the ratio of 
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true positives identified by the test out of all the individuals identified by the test to have 
a problem with drug abuse (true positives plus false positives). Finally, negative 
predictive power refers to the instrument’s ability to predict the absence of a drug abuse 
problem. This statistic is determined by calculating the ratio of true negatives (individuals 
correctly identified to not have a problem with drug abuse) out of all the individuals the 
instrument determined not to have a problem with drug abuse (true negatives plus false 
negatives).  
Structural validity is determined by using a statistical process called factor 
analysis to examine the format of an instrument and to group related items into various 
aspects of a construct by identifying which items correlate with each other (Erford, 
2021). Each group of related items represents a factor. Studies of both exploratory factor 
analysis (EFA) and confirmatory factor analysis (CFA) were of interest. An EFA is the 
process of examining structural validity when evidence of the number of factors and how 
items are grouped among factors is not available (Erford, 2021). In this process, the 
factors that represent various constructs and the items that comprise the various factors 
are determined by mathematical procedures. A CFA is the process of examining 
structural validity when theoretical evidence is used to identify the number of factors 
thought to be present and how the items load on each factor prior to the analysis.    
Descriptive statistics, including means and standard deviation values, were also 
extracted for analysis. Only means and standard deviations reported on nonclinical 
samples were analyzed as data from clinical samples are not likely to represent the 
general population parameters. 
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The data extraction process was completed by creating tables for each 
psychometric property identified in the articles. For example, one table was created to 
record all articles that reported internal consistency values of the DAST-20, including the 
article number, sample size (n), type of sample (nonclinical or clinical), and the KR-20 
coefficient. If a value was also reported specifically for men or women, these values were 
also stratified. Once the relevant data were extracted, analytic procedures were used to 
examine the psychometric properties of the DAST-20.  
Data Analysis 
Research Questions 
The following research questions were explored: 
1. What are the aggregated psychometric properties of the DAST-20 scores (i.e., internal 
consistency, test-retest reliability, diagnostic validity, structural validity, convergent 
validity)? 
2. What are the aggregated mean scores and standard deviations of the DAST-20 in 
nonclinical samples? 
3. Are there significant differences in the psychometric properties of the DAST-20 
scores among various sample characteristics? 
Statistical Analysis 
Statistical analyses were conducted on the reliability and validity data described 
above. All of the data included in the study were independent, which means that all data 
were only represented in the study once (Erford et al., 2010). When completing the article 
selection and data extraction processes, duplicate articles were deleted, and data sets 
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published in more than one accepted article were used only once in the data aggregation 
and analysis.   
Before aggregation, all data were weighted by the corresponding sample size 
before being analyzed in order to reduce sample size bias (Erford et al., 2015). According 
to classical test theory, an observed score is comprised of the true score and an error of 
measurement (Erford, 2021). The error of measurement is assumed to be random. As a 
result, the average of the observed scores converges on the true score because they are 
likely normally distributed. Therefore, internal consistency coefficients were weighted by 
sample size and then averaged together to get aggregated reliability data. This process 
was repeated for test-retest reliability aggregations. When interpreting the reliability 
coefficient, coefficients .80 and higher are considered to be acceptable for screening 
purposes and coefficients of .90 and above are acceptable for diagnostic purposes. 
Unlike analysis of the reliability statistics, validity coefficients cannot be analyzed 
by operating under the assumption of true score and error variance because systematic 
error must be considered (Erford, 2021; Erford et al., 2015). Therefore, Pearson r 
coefficients were converted to z-values before being weighted by sample size and 





For each convergent validity comparison, the Pearson r statistic was converted to a z-
score, then weighted by sample size and averaged. Finally, the averaged z-scores were 
converted back to Pearson r coefficients. To interpret the Pearson r coefficients, the 
following effect sizes were used, as recommended by Lipsey and Wilson (2001): 0.1 




Evidence of diagnostic validity, as described above, was aggregated as possible 
across the indices of percent of correct classifications, specificity values, sensitivity  
values, positive predictive values, and negative predictive values. For each cut off score 
on a similar criterion, index values were weighted by sample size, aggregated, and then 
averaged. Evidence of structural validity was extracted from the accepted articles and 
reported in table format. Finally, means and standard deviations of nonclinical samples 
were weighted by sample size and averaged across studies.   
Chapter 3 Summary 
 In chapter 3, the methodology for this study was reviewed. The research design 
for this study is a psychometric synthesis, which uses specific procedures to collect and 
analyze psychometric data from available research on a given topic of interest. The 
procedures include setting criteria, completing an article search, screening articles for 
inclusion in the study, data extraction, and data analysis. Data analysis was conducted on 
reliability data (internal consistency, test-retest reliability), validity data (convergent 
validity, structural validity, diagnostic validity), and means and standard deviations of 




CHAPTER 4: RESULTS 
Introduction 
 Psychometric synthesis procedures (Erford et al., 2015) were conducted and the 
available data on the psychometric properties (i.e., internal consistency, test-retest 
reliability, convergent validity, structural validity, diagnostic validity, descriptive 
statistics) of the DAST-20 (Skinner, 1982a) were analyzed as outlined in Chapter 3. In 
this chapter, the results of the article search and selection are reported and a detailed 
report of the data and analysis procedures are provided.  
Sample 
A total of 839 articles were produced by the electronic database search and 14 
additional articles were found by hand searching candidate article reference lists, 
resulting in a total of 853 potential articles screened for the study. In order to be selected 
for inclusion into the study each article had to be in English, published between 1982 and 
2014, use the English version of the 20-item DAST, and report at least one type of data 
on the psychometric properties of the instrument. The selection process produced a total 
of 56 articles accepted into the psychometric synthesis. Out of the 56 articles, 34 articles 
provided data on internal consistency, three articles provided data on test-retest 
reliability, 17 articles provided data on convergent validity, three articles provided data 
on factor analysis, seven articles provided data on diagnostic validity, and 12 studies 
provided mean and standard deviation descriptive statistics on the DAST-20 for 
nonclinical samples. 
The author and a committee member screened each of the 853 articles for relevant 
data and the required criteria for inclusion into the study. The interrater agreement for 
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article selection and inclusion was 94.8%, an inter-rater correlation of r = .851 (p < .001), 
both indicators of strong inter-rater concordance (Erford, 2021). Any disagreement in 
inclusion decisions were discussed until consensus was achieved.  
DAST-20 Reliability 
 In the present study, data on the reliability of the DAST-20 scores was collected, 
including evidence of internal consistency (i.e., KR-20) and test-retest reliability (i.e., 
Pearson r). The results are summarized below.  
Internal Consistency 
A total of 33 articles (j = 33) accepted into the current study provided internal 
consistency data (KR-20). One of these articles included coefficient alpha values for three 
independent sample groups, resulting in a total of 35 internal consistency scores included 
in the aggregation (k = 35) and a total sample size of 15,546 (see Table 1). Each KR-20 
was weighted by the corresponding sample size. The aggregated total DAST-20 internal 
consistency for this study embedded within a 95% confidence interval was KR-20 = 
.819[.819, .820]. 
Table 1: Total Aggregated Internal Consistency  
Article  N KR-20 N x KR-20 
Aubry et al. (2012)  329 .93 305.97 
Bliss et al. (2008) 178 .91 161.98 
Boyd et al. (2009) 142 .96 136.32 
Brocato & Wagner (2008) 141 .75 105.75 
Burnett et al. (2013) 1,874 .78 1461.72 
Cassidy et al. (2008) 84 .998 83.832 
Cocco & Carey (1998) 97 .92 89.24 
Fineran et al. (2010) 200 .91 182.00 
Fleury et al. (2012)  2,443 .74 1807.82 
Forbey et al. (2008)  1,038 .81 840.78 
Forbey et al. (2011)  213 .95 202.35 
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Forbey et al. (2013) sample a  1,065 .81 862.65 
Forbey et al, (2013) sample b 613 .93 570.09 
Forbey et al. (2013) sample c  164 .94 154.16 
Irving & Schweiger (1991)  400 .77 308.00 
Kaslow et al. (2006) 274 .94 257.56 
Kimbrel et al. (2011) 162 .77 124.74 
Looman & Abracen (2013) 348 .90 313.20 
Mowbray et al. (2006) 379 .94 356.26 
Murphy et al. (2007) 139 .90 125.10 
Nelson et al. (2011)  1,637 .77 1260.49 
Nochajski et al. (2013)  520 .82 426.40 
Nordfjærn (2013) 203 .795 161.385 
Perepletchikova et al. (2012)  99 .96 95.04 
Reviere et al. (2007)  200 .92 184.00 
Rosenkranz, Muller et al. (2012)  216 .71 153.36 
Rosenkranz, Henderson et al. (2012) 188 .72 135.36 
Saltstone et al. (1994) 318 .88 279.84 
Skinner (1984) 223 .94 209.62 
Skinner & Goldberg (1986)  105 .74 77.70 
Stuart & Holtzworth-Munroe (2005)  86 .91 78.26 
Sullivan et al. (2009) 412 .86 354.32 
Teslak (2000) 142 .90 127.80 
Weber (2008)   824 .81 667.44 
Weinstein (1999) 90 .88 79.20 
Total 15,546  12,739.737 
 
A total of seven articles (j = 7) accepted into the current study provided internal 
consistency data (KR-20) for female participants. The articles resulted in a total sample 
size of 1,903 (see Table 2). Each coefficient α was weighted by the corresponding sample 
size. The aggregated total DAST-20 internal consistency for females was KR-20 = 




Table 2: Internal Consistency - Females 
Article  N KR-20 N x KR-20 
Bliss et al. (2008)  178 .91 161.98 
Boyd et al. (2009)  142 .96 136.32 
Kaslow et al. (2006)  274 .94 257.56 
Mowbray et al. (2006)  379 .94 356.26 
Reviere et al. (2007)  200 .92 184.00 
Saltstone  et al. (1994)  318 .88 279.84 
Sullivan et al. (2009)  412 .86 354.32 
Total 1,903  1,730.28 
 
A total of seven articles (j = 7) accepted into the current study provided internal 
consistency data (KR-20) for male participants. One article provided two samples, 
resulting in a total of eight internal consistency values that were aggregated (k = 8). The 
articles resulted in a total sample size of 1,846 (see Table 3). Each coefficient was 
weighted by the corresponding sample size. The aggregated total DAST-20 internal 
consistency for males was KR-20 = .908[.862, .954).  
 
Table 3 – Internal Consistency - Males 
Article  N KR-20 N x KR-20 
Brocato & Wagner (2008)  141 .75 105.75 
Forbey et al. (2011) 213 .95 202.35 
Forbey et al. (2013) sample b 613 .93 570.09 
Forbey et al. (2013) sample c 164 .94 154.16 
Looman & Abracen (2013)  348 .90 313.20 
Murphy et al. (2007) 139 .90 125.10 
Stuart & Holtzworth-Munroe (2005) 86 .91 78.26 
Ting (2009) 142 .90 127.80 
Total 1,846  1,676.71 
 
A total of six articles (j = 6) accepted into the current study provided internal 
consistency data (KR-20) for nonclinical samples. One article provided two samples, 
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resulting in a total of seven aggregated internal consistency values (k = 7). The articles 
resulted in a total sample size of n = 7,319 (see Table 4). Each KR-20 was weighted by 
the corresponding sample size. The aggregated total DAST-20 internal consistency for 
the nonclinical samples was KR-20 = .793[.770, .816].  
 
Table 4 – Internal Consistency – Nonclinical Samples 
Article  N KR-20 N x KR-20 
Burnett et al. (2013) 1,874 .78 1,461.72 
Fineran et al. (2010) 200 .91 182.00 
Fleury et al. (2012) 2,443 .74 1,807.82 
Forbey & Ben-Porath (2008) 1,038 .81 840.78 
Forbey et al. (2013) sample a 1,065 .81 862.65 
Forbey et al. (2013) sample b 613 .93 570.09 
Stuart & Holtzworth-Munroe (2005) 86 .91 78.26 
Total 7,319  5,803.32 
 
Clinical sample results were also aggregated and included a total of 28 articles 
and studies (j = 28; k = 28) accepted into the current study that provided internal 
consistency data (KR-20) for clinical samples. The articles resulted in a total sample size 
of 8,227 (see Table 5). Each coefficient was weighted by the corresponding sample size. 
The aggregated total DAST-20 internal consistency for clinical samples was KR-20 = 
.843[.821, .865].  
 
Table 5 – Internal Consistency – Clinical Samples 
Article N KR-20 N x KR-20 
Aubry et al. (2012) 329 .93 305.97 
Bliss et al. (2008)  178 .91 161.98 
Boyd et al. (2009)  142 .96 136.32 
Brocato & Wagner (2008)  141 .75 105.75 
Cassidy et al. (2008)  84 .998 83.832 
Cocco & Carey (1998) 97 .92 89.24 
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Forbey et al. (2011) 213 .95 202.35 
Forbey et al. (2013) sample c 164 .94 154.16 
Looman & Abracen (2013) 348 .90 313.20 
Mowbray et al. (2006)  379 .94 356.26 
Murphy et al. (2007) 139 .90 125.10 
Irving & Schweiger (1991)  400 .77 308.00 
Kaslow et al. (2006)  274 .94 257.56 
Kimbrel et al. (2011)  162 .77 124.74 
Nelson et al. (2011) 1,637 .77 1,260.49 
Nordfjærn (2013)  203 .795 161.385 
Nochajski et al. (2013) 520 .82 426.40 
Perepletchikova et al. (2012)  99 .96 95.04 
Reviere et al. (2007)  200 .92 184.00 
Rosenkranz, Muller et al. (2012) 188 .72 135.36 
Rosenkranz, Henderson et al. (2012) 216 .71 153.36 
Saltstone et al. (1994)  318 .88 279.84 
Skinner (1984) 223 .94 209.62 
Skinner & Goldberg (1986)  105 .74 77.70 
Sullivan et al. (2009)  412 .86 354.32 
Ting et al.  (2009) 142 .90 127.80 
Weber (2008) 824 .81 667.44 
Weinstein (1999) 90 .88 79.20 
Total 8,227  6,936.417 
 
Test-retest Reliability and Other Measures of Consistency 
 Only one article included in the current study reported data on test-retest 
reliability. Peters et al. (2000) reported a test-retest reliability value (rtt) of .95[.70, 1.00; 
n = 60] with a 72-hour period between test administrations.  
Somewhat relatedly, Cocco and Carey (1998) reported intraclass correlations with 
an ICC value of .78[.58, .98; n = 97]. The period of time between test administrations 
was between 7-43 days depending on the participant.  
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In addition, Conner et al. (2004) reported an interrater reliability of .62[.34, .90; n 
= 48] between a participant’s self-report and their partner’s report of the participant’s 
drug abuse.  
DAST-20 Validity 
 Data on the score validity of the DAST-20 was collected, including evidence of 
convergent validity (i.e., Pearson r), structural validity (i.e., confirmatory factor analysis, 
exploratory factor analysis), and diagnostic validity (i.e., overall accuracy, sensitivity, 
specificity, positive predictive power, negative predictive power). The results are 
summarized below.  
Convergent Validity 
 Evidence of convergent validity was most commonly reported as Pearson r 
coefficients. A total of 17 articles reported convergent validity data on the DAST-20. 
Only two instruments (not including correlations between the DAST-20 and other forms 
of the DAST) were used in multiple studies and aggregated. The first instrument reported 
in multiple studies is the Michigan Alcoholism Screening Test (MAST; 25-items) (see 
Table 6). A total for four studies (j = 4; k = 4), with a combined sample size of 766, 
included Pearson r values between the DAST-20 and the MAST (25-item version). Three 
of the four studies reported a positive correlation between the MAST and the DAST-20 
and one study (Gavin et. al, 1989) reported a negative correlation between the two 
instruments. After converting each Pearson r value to z-values, weighting the value by 
sample size (z x n), averaging the scores, and converting the aggregated z-score back to a 
Pearson r value, the aggregated correlation was r = .11[.04, .18], a no to small effect size 
(Cohen, 1988).  
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Table 6 – Correlation with the Michigan Alcohol Screening Test (MAST; 25 items) 
 
The second instrument that had multiple correlation coefficients reported (j = 2; k 
= 2; n = 6,504) with the DAST-20 is the Alcohol Dependence Scale (ADS) (see Table 7). 
Similar to the MAST (25-item) correlation, Gavin et al. (1989) found a negative 
correlation between the DAST-20 and the ADS, while Shuggi et al. (2006) reported a 
positive correlation between the two instruments. The aggregated convergent validity 
value for the DAST-20 and the ADS is r = 0.27[.25, .29], a small to medium effect size.   
Table 7 – Correlation with the Alcohol Dependence Scale 
Article N r z-value z x n 
Gavin et al. (1989) 501 -.13 -0.131 -65.13 
Shuggi et al. (2006) 6,003 .30 0.310 1,860.93 
Total 6,504   80.104 
 
Although the ADS and the MAST (25-item) were the only instruments with 
multiple correlation data with the DAST-20, a total of 27 additional instruments or 
subscales had a single report of convergent validity data with the DAST-20. One study 
(Møller & Linaker, 2010) reported phi coefficients, whereas all other articles reported r 
values. Moller and Linaker (2010) reported a phi value of .41 (n = 37) for the ICD-10 and 
the DAST-20 and a phi value of .34 (n = 37) for the DUS and DAST-20. The convergent 
validity (r) data of the other instruments are reported in Table 8.  
Table 8 – Additional Convergent Validity Correlations with DAST-20. 
Article Instrument n r 
Alexander & Leung 
(2006)  
Marijuana Screening Inventory (MSI-X) 107 .531 
Article  N r z-value z x n 
Cocco & Carey (1998) 97 .52 0.576 55.872 
Gavin et al. (1989) 501 -.19 -0.192 -96.192 
Marshall & Marshall (2006) 80 .56 0.633 50.64 
Weinstein (1999) 88 .659 0.793 69.784 
Total 766   80.104 
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Alterman et al. (2007)  Addiction Severity Index – 5th Edition 
(ASI-5) Recent Drug Problems 
2,142 .65 
ASI-5 Lifetime Drug Problems 2,142 .63 
Brocato & Wagner 
(2008)  
DSM-IV TR Checklist 141 .66 
Cocco & Carey 
(1998)  
Addiction Severity Index (ASI) – Drug 
Composite Score 
97 .42 
Clinician Rating Scales for Drug Use 
(CRS-Drug) 
97 .40 
ASI – Alcohol Composite Score 97 .33 
Global Assessment of Functioning (GAF) 97 -.14 








Forbey et al. (2011) Minnesota Multiphasic Personality 
Inventory 2 (MMPI-2) 
159 .52 
MMPI-2 MAC-R (MacAndrew Alcoholism 
Scale-Revised) 
159 .35 
MMPI-2 AAS (Addiction 
Acknowledgement Scale) 
159 .46 
MMPI-2 APS (Addiction Potential Scale) 159 .45 
Gavin et al. (1989) DSM-III Drug Addiction Diagnosis 
(Current) 
501 .75 
DSM-III Drug Addiction Diagnosis 
(Lifetime) 
501 .74 
DSM-III Alcohol Addiction Diagnosis 
(Current) 
501 -.31 
DSM-III Alcohol Addiction Diagnosis 
(Lifetime) 
501 -.25 
Hall et al. (2007) Externalizing Inventory and Criterion 
Measure (100-item) 
90 .61 
Hormes et al. (2012) Obsessive Compulsive Cocaine Use Scale 
(OCCUS) Total 
107 .42 
OCCUS - Obsessive 107 .27 
OCCUS – Compulsive  107 .47 
Reviere et al. (2007) Michigan Alcoholism Screening Test (10-
item) 
200 .54 
Teslak (2000) CAGE Drug Test (CAGE D) 70 .52 
SASSI-2 Face Valid Other Drugs (FVOD)  70 .49 




 Three articles provided convergent validity data on the DAST-20 and two other 
forms of the DAST. Aggregated correlations between the DAST-20 and DAST-10 are 
summarized in Table 9. Skinner (1984) produced a correlation with the DAST (28-items) 
with a sample size of 223 of r = .99[.86, 1.00]. Two articles (see Table 9) produced 
correlations with the DAST-10 (j = 2; k = 2) with a total sample size of 320. After 
converting r values to z-values, weighting by corresponding sample sizes, and converting 
the aggregated z-score back to an r value, the averaged correlation coefficient for the 
DAST-20 and DAST-10 was r = .98[.87, 1.00]. 
Table 9 – Convergent Validity between DAST-20 and DAST-10 
 
Structural Validity 
 Three articles provided evidence of structural validity, including one confirmatory 
factor analysis (Cocco & Carey, 1998) and three exploratory factor analyses (Cocco & 
Carey, 1998; Saltstone et al., 1994; Skinner & Goldberg, 1986). Varying findings are 
reported below and implications discussed in Chapter 5. 
Confirmatory Factor Analysis 
 Cocco and Carey (1998) performed a confirmatory factor analysis on the DAST-
20 administered to a sample of only 100 participants, resulting in a poor fit for the 
unidimensional model (X2 = 473.23, p < .001; GFI = .72; AGFI = .65). With only 100 
participants, this CFA was significantly underpowered. 
 
 
Article N r z-value z x n 
Cocco & Carey (1998) 97 .97 2.092 202.924 
Skinner (1984) 223 .98 2.298 512.454 
Total 320   715.378 
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Exploratory Factor Analysis 
 Cocco and Carey (1998) reported a possible six-factor solution for the DAST-20. 
However, after reviewing the factor loadings, in which the first factor accounted for 41% 
of the variance and factors 2 through 6 accounted for an additional combined total of 
30% of the variance, the researchers concluded that a two-factor solution best represented 
the scale. Cocco and Carey (1998) reported factor 1 was composed of items that inquire 
about “external consequences experienced by drug use,” which included all items except 
for items 4 and 5 (factor loadings of .47 to .77) (p. 411). Factor 2 was comprised of items 
4 (factor loading = .73) and 5 (factor loading = .55). These two items “had the lowest 
item-scale correlations” (p. 411). However, with only 97 participants, this EFA was 
significantly underpowered. 
Saltstone et al. (1994) performed an exploratory factor analysis of DAST-20 
scores from 615 female participants. This analysis resulted in a five-factor solution; 
however, due to a small variance (.14) between the last two factors, Saltstone et al. 
determined the four-factor solution was most parsimonious. A second factor analysis was 
performed for four factors and accounted for 56% of the total variance. The first factor 
alone accounted for 32.5% of the variance. Factor 1 was composed of items (4, 5, 7-11, 
15, 16, 19, & 20) that inquire about drug abuse habits, social consequences, medical 
consequences, and previous treatment. Factor 2 was composed of items (12 & 13) related 
to work consequences. Similar to factor one, factor three comprised of items (2, 3, 6, 14, 
17 & 18) that inquire about drug abuse habits, medical consequences, and “aggression,” 
however different items loaded on factor 3 than on factor 1. Factor 4 included a single 
item (1) that inquired about an individual’s drug dependence; single items do not 
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constitute a factor. In addition, items 4, 5, 17, & 18 displayed significant cross loading 
between two factors.  
 The third article (Skinner & Goldberg, 1986) that explored structural validity 
reported data from an exploratory factor analysis of the DAST-20 administered to 105 
participants. The analysis resulted in a five-factor solution. Factor 1 was composed of 
three items (items 4, 5, and 17) that inquire about an individual’s drug dependence. 
Factor 2 was composed of six items (items 8 through 13) that inquire about social 
consequences. Two items loaded on factor 3 (items 6 and 18), both of which inquire 
about medical consequences related to drug abuse. Factor 4 included five items (items 1 
through 3, 14, and 16) inquiring about one’s drug abuse habits and use, as well as legal 
consequences. The two items (14 and 16) that addressed legal consequences did not load 
as highly (.54 and .42, respectively). Finally, factor 5 had two items (items 19 and 20) 
load that inquire about previous treatment. With only 105 participants, this EFA was 
significantly underpowered. 
Diagnostic Validity 
 A total of six articles reported diagnostic validity data for the DAST-20. Only two 
of these articles could be aggregated because of diverse criterion measures and cutoff 
scores. Therefore, a summary of the remaining articles is provided. Five of the articles 
reported data for similar cutoff scores (see Table 10).  
Table 10 – Diagnostic Validity Data with Comparative Cut-off Scores 
Studies n Cutoff % CC Sens Spec PPV NPV Criterion 
Alexander & Leung 
(2011) 
174 ≥6 79.1 .818 .608 __ __ DSM-G-CS 
21 
Cassidy et al. (2008) 84 6 71 .55 .86 .79 .68 SCID 
Cocco & Carey (1998) 97 5/6 81 .74 .83 __ __ DSM-HI-R 
Gavin et al. (1989) 501 5/6 85 .96 .79 .73 .97 DSM-III 
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Møller & Linaker 
(2010) 
48 ≥5 __ .86 .67 __ __ ICD-10 
Peters et al. (2000) 306 >6 82.7 .882 .805 .636 .947 SCID-IV 
 
Alexander and Leung (2011; n = 174) reported a sensitivity of .818, a specificity 
of .608, and 79.1% correctly classified for a cutoff score of 6 or greater. The criterion 
used was the DSM-G-CS 21. Møller and Linaker (2010; n = 48) reported a sensitivity 
value of .86 and a specificity of .67 for a cutoff score of 5 or greater. Cassidy et al. (2007; 
n = 84) had optimal results at a cutoff score of 3 using the SCID as the criterion measure. 
At this cutoff score, the sensitivity value was .85, the specificity value was .73, the PPV 
was .74, and the NPV was .84, with 79% of participants correctly identified. However, 
with the traditionally recommended cutoff score of 6, Cassidy et al. (2007) reported a 
sensitivity of .55, a specificity of .86, a PPV of .79, a NPV of .68 and 71% of participants 
were correctly classified. Coco and Carey (1998) reported diagnostic validity data on a 
sample of 97 individuals using the DSM-HI-R criterion for drug use disorder. Optimal 
sensitivity and specificity results were found with a cutoff score of 2/3 (sensitivity = .89, 
specificity = .68, %CC = 72) and 5/6 (sensitivity = .74, specificity = .83, %CC = 81). 
Using the DSM-III as the criterion measure, Gavin, et al. (1989; n = 501) found that the 
percent of individuals correctly identified was 85 between the cutoff scores of 5/6 and 
9/10. Sensitivity and specificity values were closest (.88 and .84, respectively) at a cutoff 
score of 6/7. Finally, Peters et al. (2000; n = 306) reported diagnostic validity for the 
DAST-20 for a cutoff score of 6 or greater using the SCID-IV as the criterion measure. 
The sensitivity was .882, specificity .805, PPV .636, NPV .947, and 82.7% of individuals 
were correctly classified.  
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An aggregation of Coco and Carey (1998) and Gavin et al.’s (1989) diagnostic 
validity data was completed (see Table 11) as the two studies reported cutoff scores in the 
same format and used a version of the DSM as the criterion.  
Table 11 – Aggregated Diagnostic Validity Data for Cocco and Carey (1998) and 
Gavin et al. (1989) (n = 598, j =2) 
Cutoff Score Sensitivity Specificity %CC 
0/1 1.00 .385 59.1 
1/2 .992 .542 69.9 
2/3 .982 .663 77.9 
3/4 .974 .723 81.2 
4/5 .957 .765 83.3 
5/6 .924 .796 84.4 
6/7 .881 .820 84.7 
7/8 .831 .850 84.7 
 
Descriptive Statistics 
 Means and standard deviations reported for nonclinical samples were extracted 
and aggregated. A total of 12 articles (j = 12) included in the current study provided data 
for nonclinical samples, with six articles providing data on multiple nonclinical groups (k 
= 19). The combined total sample size was 2,617. Each mean and standard deviation was 
weighted by sample size and aggregated. The total average mean is 1.083 and the total 
average standard deviation is 1.620. These results are summarized in Table 12. 
Table 12 - DAST-20 Descriptive Statistics of Nonclinical Samples 
Article N M N x M SD N x SD 
Aubry et al. (2012)  89 0.0 0.0 0.0 0.0 
Burnett et al. (2013) sample a 552 2.1 1,159.2 2.8 1,545.6 
Burnett et al. (2013) sample b 1,322 1.1 1,454.2 1.7 2,247.4 
Ersche et al. (2010) sample a  30 0.0 0.0 0.0 0.0 
Ersche et al. (2010) sample b 30 0.4 12.0 1.0 30.0 
Ersche et al. (2012) sample a 50 0.0 0.0 0.0 0.0 
Ersche et al. (2012) sample b 50 0.5 25.0 1.1 55.0 
Ersche et al. (2013) sample a 52 0.0 0.0 0.0 0.0 
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Ersche et al. (2013) sample b 50 0.5 25.0 1.1 55.0 
Fineran et al. (2010) sample a 79 0.23 18.17 0.97 76.63 
Fineran et al. (2010) sample b 79 0.34 26.86 0.85 67.15 
Fineran et al. (2010) sample c 7 0.14 0.98 0.38 2.66 
Gizewski et al. (2013)  12 0.8 9.6 0.8 9.6 
Levy (2013) 22 1.5 33.0 1.4 30.8 
Morein-Zamir et al. (2013) sample a 39 .36 14.04 .74 28.86 
Morein-Zamir et al. (2013) sample b 41 0.0 0.0 0.0 0.0 
Schiffer et al. (2010) 14 0.9 12.6 0.9 12.6 
St. Germain & Hooley (2012)  68 0.4 27.2 0.7 47.6 
Weinborn et al. (2011) 31 0.5 15.5 1.0 31.0 
Total 2,617  2833.35  4,239.9 
 
Chapter 4 Summary 
In this chapter, the results of the article search and selection were reported. 
Further, the psychometric properties (i.e., internal consistency, test-retest reliability, 
convergent validity, structural validity, diagnostic validity, descriptive statistics) of the 
DAST-20 (Skinner, 1982a) were summarized. In Chapter 5, the results will be interpreted 
and I will discuss the significance of the findings, limitations of the study, and 




CHAPTER 5: DISCUSSION 
Introduction 
 The current study examined the psychometric properties of the DAST-20 
(Skinner, 1982a) following psychometric synthesis procedures outlined in Chapter 3. 
Various factors in research studies can contribute to variations in reported psychometric 
properties of the instrument, which can have an impact on how clinicians and researchers 
use and interpret the results of the DAST-20 (Erford et al., 2010; Lipsey & Wilson, 
2001). This is significant because researchers and clinicians are required to provide care 
that is supported by research and ethical guidelines, including examining the 
psychometric properties and empirical data of the instrument and considering 
multicultural facets when using the instrument (ACA, 2014). This study aimed to provide 
an overview and aggregated results of all relevant data on the DAST-20 in order to 
provide a more comprehensive and clear picture of the psychometric properties of the 
instrument.  
This psychometric synthesis of the DAST-20 included data from 56 articles and 
provided aggregated results of internal consistency, test-retest reliability, convergent 
validity, structural validity, diagnostic validity, and descriptive statistics of the 
instrument. Overall, the aggregated data produced adequate to excellent score reliability 
coefficient values for a screening instrument. The validity data was more diverse, with 
varying structural analysis reports and reported cutoff scores when examining diagnostic 
validity. In this chapter, interpretation of the results from Chapter 4 and implications will 
be discussed in detail. Then, limitations of the study, recommendations for clinicians, and 




Three research questions formed the basis of this study: 
1. What are the aggregated psychometric properties of the DAST-20 scores across 
published studies (i.e., internal consistency, test-retest reliability, diagnostic 
validity, internal structural validity, external convergent validity)? 
2. What are the mean scores and standard deviations of the DAST-20 in nonclinical 
samples across published studies? 
3. Are there significant differences in the psychometric properties of the DAST-20 
scores among various sample characteristics (e.g., gender)? 
Discussion of Results 
 The first research question inquired about the aggregated psychometric properties 
of the DAST-20 scores, including internal consistency, test-retest reliability, diagnostic 
validity, structural validity, and convergent validity. When determining the efficacy of 
internal consistency estimates, Erford (2021) recommended values of at least .80 to 
consider scores from an instrument acceptable for screening purposes and at least .90 for 
use as a diagnostic tool. From the initial psychometric examination of the DAST-20 
scores, Skinner (1984) reported an excellent internal consistency for the total sample and 
a good internal consistency for a subsample that omitted participants reporting only 
alcohol abuse. Both of these estimates indicate that the DAST-20 is adequate for 
screening purposes, although, the subsample size is small. The internal consistency 
estimate of the subsample, which included individuals who reported only drug abuse or 
drug abuse and alcohol abuse and omitted those who reported only alcohol abuse is likely 
to be more similar to the current sample because the DAST-20 instructions specify that 
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the items do not inquire about alcohol use. The aggregated internal consistency value 
from the current study was slightly lower than the initial subsample, although still 
indicative of an adequate reliability for a screening instrument.  
Of the studies included in this study that reported internal consistency values, 
there was a disparity between sample size and KR-20 values. Samples that were over 
1,000 participants had lower internal consistency estimates than the studies with a smaller 
sample size. All of these larger studies, except for one consisted of a nonclinical sample. 
Therefore, the lower internal consistency scores among these studies can be attributed to 
homogeneity of scores, as nonclinical samples tend to have a very large percentage of 
low scores with many individuals scoring 0 on the instrument.  
Out of the 33 articles reporting internal consistency data, seven articles provided 
data for female participants (see Table 2) and seven articles provided data for male 
participants (see Table 3). The aggregated data was consistent among males and females 
and provided evidence of excellent internal consistency for females and males scores. 
The internal consistency estimates for gender groups were significantly higher than for 
the total sample, but they included a much smaller sample size.  
The sample also was divided into clinical and nonclinical subsamples in order to 
assess internal consistency estimate differences between the two groups. The aggregated 
internal consistency score estimate for the clinical subsample was slightly higher than the 
estimate for the overall sample (see Table 5). The internal consistency estimate calculated 
for the nonclinical subsample was significantly lower (see Table 4). This estimate falls 
just below the cutoff considered adequate for screening tests.  
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 Only two articles reported evidence of test-retest reliability for the DAST-20 
scores and each of the studies reported different types of evidence and varying 
timeframes of test administration, which did not allow for aggregation of the data. Peters 
et al. (2000) reported excellent test-retest score reliability over a period of 72 hours. 
Although the sample was small, the results indicate more than adequate test-retest 
reliability of the DAST-20 scores for screening purposes over a 72-hour timeframe. 
Cocco and Carey (1998) reported evidence of lower test-retest reliability. Again, the 
sample size was under 100 participants and the timeframe between test administrations 
was inconsistent in that study (readministering the test anywhere between 7 to 43 days for 
each participant). The inconsistency of test administration could have had an effect on the 
reported reliability. Further, the longer gap between test administrations could contribute 
to the lower reliability scores (Bressler et al., 2018). Finally, Conner et al. (2004) 
reported interrater reliability between the participant’s self-report of drug abuse and their 
significant other’s report of the participant’s drug abuse using the DAST-20. The sample 
size of this study is smaller than what is considered ideal. 
 Evidence of convergent validity among scores from included studies ranged from 
-.13 to .75 depending on the instrument being correlated with the DAST-20. The MAST 
(25-items; see Table 6) and the ADS (see Table 7) were the only two instruments with 
multiple convergent validity data reported in multiple studies. The aggregated convergent 
validity estimate for both the MAST and the ADS indicated small correlations. Both 
convergent instruments measure problems related to alcohol use, whereas the DAST-20 
excludes alcohol when assessing drug abuse. Among the other 27 instruments (see Table 
8) with one source of data of convergent validity with the DAST-20 scores, six 
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instruments or subscales measured alcohol use, including the Alcohol Composite Score, 
the MMPI-2 MAC-R, the DSM-III Alcohol Addiction Diagnosis current and lifetime, the 
MAST (10-item), and the AUDIT (10-item). All of the convergent validity estimates 
indicated medium to large correlations (effect sizes) between the DAST-20 and each 
instrument scores.  
These estimates may support the ability of the DAST-20 scores to discriminate 
between alcohol abuse and drug abuse during the screening process. Medium to strong 
correlation values were reported for the DAST-20 and the Marijuana Screening Inventory 
(MSI-X), the Addiction Severity Index - Recent Drug Problems (ASI-5) and Lifetime 
Drug Problems, Addiction Severity Index – Drug Composite Score, Clinician Rating 
Scales for Drug Use, DSM-III Drug Addiction Diagnosis - Current and Lifetime, 
Obsessive Compulsive Cocaine Use Scale – Total, the CAGE Drug Test, and the SASSI-
2 Face Valid Other Drugs. These estimates support convergent validity between the 
DAST-20 scores and other instruments measuring drug abuse, yielding medium to large 
effect sizes (Cohen, 1988).  
Cocco and Carey (1998) reported a negative, small convergent validity estimate 
between the DAST-20 and the Global Assessment of Functioning (GAF). As discussed in 
Chapter 2, drug abuse has been shown to result in negative consequences in various 
aspects of an individual’s life. Therefore, it seems logical that as scores increase on the 
DAST-20 (indicating more consequences of drug abuse) then scores on the GAF would 
decrease (indicating lower levels of functioning in various aspects of life).  
Finally, multiple studies reported evidence of convergent validity between the 
DAST-20 and other forms of the instrument. Skinner (1984) reported a strong correlation 
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between the DAST (28-items) and the DAST-20. Aggregated convergent validity data for 
the DAST-20 and the DAST-10 indicated a strong, positive correlation. These findings 
suggest that clinicians and researchers should chose the form of the instrument based on 
the recommended uses. For example, The DAST-20 is recommended for use in clinical 
settings and for research evaluation (Skinner, 1984).  
 Varying findings were reported for the structural validity of the DAST-20. Cocco 
and Carey (1998) was the only study that performed a confirmatory factor analysis based 
on the original finding of a one-factor solution, with an undersized sample. EFA and CFA 
typically requires 10 participants per item to yield reliable results (Tabachnik & Fidell, 
2019). At 100 participants for 20 items, the analyses were significantly underpowered. 
Cocco and Carey decided to run an exploratory factor analysis after the confirmatory 
factor analysis did not support a one-factor solution.  
Three studies performed an exploratory factor analysis on the DAST-20 and all 
three studies came to different conclusions. Cocco and Carey (1998) reported a two-
factor solution, Saltstone et al. (1994) reported a four-factor solution, and Skinner and 
Goldberg (1986) reported a five-factor solution. Differences in sample characteristics and 
the primarily small sample sizes could have affected the factor analysis results of the 
instrument. Two of these three studies were underpowered with sample sizes of 97 and 
105 and each consisted of about 75% males and 25% females. The study conducted by 
Saltstone et al. (1994) was not underpowered, however the sample consisted of only 
females. It also appears that some of the items had significant cross-loading on multiple 
factors with less than .1 difference. This could affect the interpretation of the loadings. 
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Unfortunately, from the available data, a preliminary conclusion of an EFA factor 
solution of the DAST-20 cannot be made and further research is needed.  
 Diagnostic validity of the DAST-20 was analyzed, including examining percent 
correctly classified, sensitivity, specificity, positive predictive values, and negative 
predictive values. Adequate data was not reported in most of the articles reporting on 
diagnostic validity of the instrument. Skinner (1982a) originally recommended a cutoff 
score of 6 or greater to determine an individual’s need for further evaluation of drug 
abuse, but also specified that more research needed to be completed. Multiple articles 
provided data for a cutoff of 5/6 or greater, with a range of 71 to 85 percent correctly 
classified. This range was used following the recommendation of Skinner (1982a) and 
did not provide further statistics for other cutoff scores. Therefore, it is not possible to see 
if there were more optimal cutoff scores for these studies. The six studies also used 
different criterion measures (i.e., various DSM versions, ICD). Due to the lack of data 
and differences in criteria, only two studies (Cocco & Carey, 1998; Gavin et al., 1989) 
provided enough data using similar criterion measures to be aggregated. The results of 
this aggregation is in agreement with Skinner’s (1982a) original cutoff recommendation, 
with a maximum percent correctly classified of 84.7 at a cutoff score of 5/6 and higher. 
However, Cocco and Carey (1998) independently reported optimal sensitivity and 
specificity results at a cutoff of 2/3. The sample size of Cocco and Carey’s study was 
significantly smaller than the second study accounting for only 97 of the 598 individuals 
in the study and, therefore had less impact on the overall findings. Cassidy et al. (2007) 
reported an optimal cut-off of 3. These lower cut-off scores are in agreement with the 
data collected for the second research question of this study. 
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 The second research question inquired about the mean scores and standard 
deviations of the DAST-20 among nonclinical samples. The total average mean of 
nonclinical samples is 1.083 with an average standard deviation of 1.620 (see Table 10).  
In 2015, the NIH reported that four percent of adults in the United States met the criteria 
for a diagnosis of drug abuse disorder within the last year. Using this statistic, the DAST-
20 cut-off score at the 96th percentile is about 3.9. This lower cut-off score is more 
congruent with the studies mentioned above. More research is needed to examine optimal 
cut-off scores, but the tentative conclusion is that a cutoff score of 6, as previously 
recommended by Skinner (1982a) is too high to effectively and accurately identify all 
individuals who need further assessment for drug abuse. A cutoff score of four appears to 
be a more acceptable cut-off score, leading to fewer false negatives when screening for 
substance abuse.  
 Finally, the third research question inquired about the presence of significant 
differences in psychometric properties of the DAST-20 among various sample 
characteristics. Due to a lack of available data reported in the accepted publications, 
gender was the only sample characteristic that could be examined. The aggregated data 
for internal consistency was consistent among males and females and provided evidence 
of excellent internal consistency for females and males. Only a fraction of the included 
articles that reported on internal consistency provided scores for males and females, 
which contributes to the higher scores compared to the overall internal consistency 
estimates. Unfortunately, none of the studies that included nonclinical samples provided 





 As mentioned in Chapter 1, there were several delimitations prior to conducting 
the study that should be noted. One category of delimitations concerns data available 
during the time of the study. Only articles that were published in English and used the 
English version on the DAST-20 were considered for inclusion in this study. Therefore, 
potential relevant data from studies published in other languages could not be included 
(Lipsey & Wilson, 2001). Similarly, this psychometric synthesis only included articles 
that reported data from the 20-item version of the DAST, meaning that the results of this 
study should only be used to guide one’s use of the English version of the DAST-20. 
Further, this study is limited by the available data provided by included studies. Although 
the full text version of each potential study was examined for relevant psychometric data 
on the DAST-20, we were limited by what was included in the published articles. 
Therefore, without access to more detailed records, relevant data that could affect the 
overall aggregated results of the current study are potentially missing. The current study 
only includes articles that were published between 1982 (the year the DAST was 
published) and 2014 (the year that the current study was originally started). Seven years 
of recent studies need to be searched and included before publication of the results. 
 The second category of delimitations include the general limitations and 
criticisms of meta-analyses and similar types of studies such as this study (Erford et al., 
2015; Lipsey & Wilson, 2001). When completing a synthesis or meta-analysis, specific 
factors of the individual studies may become lost or unnoticed in the overall analysis. 
Critics of synthesized methodologies argue that these factors, such as limitations, cultural 
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implications, theoretical frameworks, and study quality, can have important implications 
that are not always able to be highlighted and examined in a large aggregation of studies.    
 A further limitation of this study was the lack of psychometric data reported for 
specific groups, such as race, ethnicity, different age groups, and so on. Therefore, data 
aggregation was not possible for diverse groups. Gender (male/female) was the only 
group that had sufficient reported data to complete analyses, but this was still somewhat 
limited. Mean and standard deviations of nonclinical samples were not available across 
gender, which impeded the ability to assess gender score differences. 
 Validity data in general was very limited for the DAST-20. There were only three 
available studies that reported evidence of EFA and one study that reported evidence of 
CFA. Evidence of diagnostic validity was only provided in six studies and there were 
only two instruments that had multiple convergent validity values with the DAST-20 that 
could be aggregated. All of the other instruments that had convergent validity scores with 
the DAST were only reported in one study. There were also no measurement invariance 
studies available to examine item response differences among various groups. The lack of 
data made it difficult to examine, interpret, and draw conclusions about many aspects of 
the reliability and validity estimates of the DAST-20. 
Implications for Professional Counselors 
 After examination of the results of this study, several implications are apparent 
for clinical practice, test administration and interpretation for clinicians and researchers, 
as well as recommended future research to shed further light on the use of the DAST-20. 
Implications of instrument use and recommendations are provided in this section. 
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 Overall, the DAST-20 seems to yield reliable and valid scores to screen for the 
presence of consequences related to an individual’s drug abuse, however, there is need 
for more research on the psychometric properties of the DAST-20. Recommendations for 
professional counselors are provided below. 
 As previously mentioned, there was limited data available to compare the DAST-
20 psychometric properties among various cultural groups (i.e., race, ethnicity, age, 
gender). Therefore, counselors should consider multicultural factors that may impact the 
results of the instrument until more research can be conducted to examine the use of the 
DAST-20 with various groups.  
 Clinicians should only use the DAST-20 as a screening instrument and not as a 
diagnostic tool. Further, Skinner (1982a) indicated that the instrument is not intended to 
provide a comprehensive assessment of all aspects of drug abuse. Therefore, counselors 
should use this instrument in conjunction with other sources of data collection in relation 
to a client’s drug abuse. One area of drug abuse consequences not adequately assessed by 
the DAST-20 are psychological consequences. In the literature, many psychological 
consequences have been cited related to an individual’s use of drugs, however, the 
DAST-20 does not directly assess the presence of these consequences. Other screening 
instruments should be used to get a more complete picture of how drug abuse is affecting 
an individual’s psychological health and vice versa.   
 Instruments that rely solely on self-report can be at risk for underreporting of 
issues by a client (Erford, 2021). Skinner (1982a) indicated the risk of underreporting on 
the DAST. In the current study, no correlations were reported between social desirability 
scales and the DAST-20. Underreporting of drug abuse can lead to misidentification for 
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further assessment and treatment, as well as inadequate treatment plans. Therefore, it is 
recommended that professional counselors use a social desirability instrument in 
conjunction with the DAST-20 to provide evidence of whether a client may be 
underreporting issues related to drug abuse. 
 Significant differences are apparent between the aggregated psychometric 
estimates found in this study and the estimates reported in the original study of the 
DAST-20. The internal consistency estimate from this study was much lower than the 
original internal consistency estimate provided by Skinner (1982a). This is important for 
professional counselors to consider, however, the aggregated internal consistency still 
falls in the range considered appropriate for use as a screening instrument. More 
concerning, the analysis of the aggregated data in this study indicated that the original 
cutoff score recommended by Skinner (1982a) might be too high, leading to potential 
false negatives. This means that a significant number of individuals who should be 
identified for further diagnostic evaluation could potentially be missed. Further research 
is needed to come to a more definitive conclusion about the most effective cutoff score. 
Until this data is available, professionals should consider scores in the range of three to 
six. Other instruments and forms of data collection could be used in conjunction with the 
DAST-20 when individuals score in this range to help determine whether further 
diagnostic assessment is recommended.     
Implications for Counseling Research 
To further examine evidence of reliability and validity of the DAST-20 scores, more 
research is needed. In regard to limitations of the current study, a search for all relevant 
published articles from 2015 to 2021 should be acquired and examined for data that can 
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be included in the psychometric synthesis. A future study that examines reliability and 
validity of the DAST-20 scores in studies published in languages other than English 
could provide important multicultural facets of using and interpreting the instrument. It 
would also provide a more comprehensive examination of the psychometric properties of 
the DAST-20 scores than what was accomplished with the current study. Also, other 
psychometric synthesis studies conducted on the other forms of the DAST, including the 
original 28-item DAST, the DAST-10, and the DAST-A are recommended. All of the 
instruments have been reported to be highly correlated, which would provide further 
evidence of validity, as well as implications for the appropriate use and settings for each 
instrument.   
After completing the data analysis, it was apparent that further research was 
needed to fill gaps in the data and examine conflicting data between some of the studies. 
As previously mentioned, data for individual groups were not readily available in the 
studies included in this psychometric synthesis. Due to the lack of data, multicultural 
implications cannot be identified with confidence. Although the DAST-20, overall, yields 
valid and reliable scores as a screening instrument for drug abuse, it is important that 
cultural factors are studied to make sure that it is sufficient to use among various 
populations. The ACA (2014) Code of Ethics specifies the responsibility of clinicians and 
researchers to consider possible implications of using specific instruments without 
considering cultural factors (i.e., “age, color, culture, disability, ethnic group, gender, 
race, language preference, religion, spirituality, sexual orientation, and socioeconomic 
status”) (p. 11). It is also imperative that authors publish data for individual groups in 
future research articles in order for more psychometric syntheses such as the current 
73 
 
study to have the data necessary to investigate potential differences and how they affect 
outcomes. Further, professional journal editors should require more detailed data be 
reported in accepted research articles related to multicultural implications and differences 
among groups.  
Measurement invariance was not assessed in any of the articles. Measurement 
invariance examines how individuals across diverse backgrounds respond to items on an 
instrument and how any differences can impact the way the items are interpreted. For 
example, do men and women interpret the items in the same way and therefore, do the 
results have the same meaning across gender? Not only does more validity and reliability 
data need to be collected across various groups, measurement invariance of the DAST-20 
items also should be studied. 
Conflicting evidence of structural validity was reported among studies. Some of 
these studies were underpowered. Future psychometric studies of the DAST-20 should 
include larger sample sizes of at least 500 participants. A future confirmatory factor 
analysis study using a community sample of at least 500 participants is recommended. 
Except for the original study of the DAST-20 completed by Skinner (1982) when 
creating the screening instrument, only one other study found provided evidence from a 
confirmatory factor analysis. There were only three studies included in this psychometric 
synthesis that conducted exploratory factor analyses on the DAST-20, resulting in three 
different conclusions. Also, updated procedures for interpretation of EFA have been 
established (Tabachnik & Fidell, 2019). Therefore, more EFA studies need to be 




One of the issues in comparing findings from various studies was the lack of 
consistent criterion measures. The DSM-III, DSM-IV, and the ICD were all used as 
criterion measures for diagnostic validity, making it difficult to aggregate data and make 
more definitive conclusions about cutoff scores, as well as other psychometric properties. 
In regard to the DSM, future research should examine the validity of DAST-20 scores 
when using the DSM-V as the criterion measure, as it is the most recent version of the 
manual and is widely used for substance abuse evaluation. It must be noted that these 
studies might already exist, as the current study only accepted articles up to 2014. This 
data should be added to the current analysis for an updated examination of the DAST-20. 
Only six articles included in the psychometric synthesis reported data on the diagnostic 
validity of the DAST-20 and recommended multiple different cutoff scores to use when 
screening for drug abuse. More studies are needed on the diagnostic validity of the 
DAST-20 in order to gain greater agreement on cutoff scores among varying groups and 
to assess the instrument’s use as part of a diagnostic protocol.  
Finally, as mentioned in the recommendation section for professional counselors, 
none of the studies included in the current study reported correlation estimates for the 
DAST-20 and a social desirability scale. Skinner (1982a) acknowledged that the DAST 
does not prevent or detect underreporting of substance abuse. Therefore, studies 
examining the use of the DAST-20 and social desirability scales could shed light on how 
underreporting affects DAST-20 scores, especially diagnostic validity and how these 






 This chapter discussed the interpretation of the results of the psychometric 
synthesis of the DAST-20 and the significance of the findings. Findings conclude that 
counselors should use the instrument with clients with confidence, as the overall 
reliability and validity estimates are adequate. However, some of the data was limited and 
further research is recommended to continue to examine the DAST-20, such as 
multicultural implications. Limitations of the study were discussed and recommendations 





* = Article accepted into the synthesis. 
*Alexander, D., & Leung, P. (2006). The Marijuana Screening Inventory (MSI-X):  
Concurrent, convergent and discriminant validity with multiple measures. The  
American Journal of Drug and Alcohol Abuse, 32(3), 351-378.  
 https://doi.org/10.1080/00952990600753594 
*Alexander, D., & Leung, P. (2011). The DSM Guided Cannabis Screen (DSM-G-CS):  
Description, reliability, factor structure and empirical scoring with a clinical  
sample. Addictive Behaviors, 36(11), 1095-1100. 
https://doi.org/10.1016/j.addbeh.2011.06.008  
*Alterman, A. I., Cacciola, J. S., Habing, B., & Lynch, K. G. (2007). Addiction Severity  
Index recent and lifetime summary indexes based on nonparametric item response 
theory methods. Psychological Assessment, 19(1), 119-132. 
https://doi.org/10.1037/1040-3590.19.1.119 
American Counseling Association. (ACA). (2014). ACA code of ethics.  
 https://www.counseling.org/resources/aca-code-of-ethics.pdf  
American Psychiatric Association. (APA). (2013). Diagnostic and statistical manual of  
mental disorders (5th ed.; DSM-5). American Psychiatric Press. 
*Aubry, T., Klodawsky, F., & Coulombe, D. (2011). Comparing the housing trajectories 
of different classes within a diverse homeless population. American Journal of  
Community Psychology, 49(1-2), 142-155. https://doi.org/10.1007/s10464-011-
9444-z  
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression  
77 
 
Inventory (2nd ed.). Psychological Corporation. 
*Bliss, M. J., Ogley-Oliver, E., Jackson, E., Harp, S., & Kaslow, N. J. (2008). African  
American women’s readiness to change abusive relationships. Journal of Family 
Violence, 23(3), 161-171. https://doi.org/10.1007/s10896-007-9138-3  
*Boyd, M. R., Berger, K. C., Baliko, B., & Tavakoli, A. (2009). Predictors of alcohol and  
drug problems in rural African American women. Issues in Mental Health  
Nursing, 30(6), 383-391. https://doi.org/10.1080/01612840802509478  
Bressler, R., Erford, B. T., & Dean, S. (2018). Systematic review of the Posttraumatic 
Stress Disorder Checklist (PCL). Journal of Counseling & Development, 96(2),  
167-187. https://doi.org/10.1002/jcad.12190 
*Brocato, J., & Wagner, E. F. (2008). Predictors of retention in an alternative-to-prison  
substance abuse treatment program. Criminal Justice and Behavior, 35(1),  
99-119. https://doi.org/10.1177/0093854807309429  
Bronson, J., & Carson, E. A. (2019). Prisoners in 2017.  
 https://www.bjs.gov/content/pub/pdf/p17.pdf   
*Burnett, A. J., Sabato, T. M., Walter, K. O., Kerr, D. L., Wagner, L., & Smith, A.  
(2013). The influence of attributional style on substance use and risky sexual  
behavior among college students. College Student Journal, 47(2), 122-136.  
*Cassidy, C. M., Schmitz, N., & Malla, A. (2008). Validation of the Alcohol Use  
Disorders Identification Test and Drug Abuse Screening Test in first episode 
psychosis. Canadian Journal of Psychiatry, 53(1), 26-33.  
https://doi.org/10.1177/070674370805300105  
*Cocco, K. M., & Carey, K. B. (1998). Psychometric properties of the Drug Abuse  
78 
 
Screening Test in psychiatric outpatients. Psychological Assessment, 10(4),  
408-414. https://doi.org/10.1037/1040-3590.10.4.408  
Cohen, J.  (1988). Statistical power analysis for the behavioral sciences (2nd ed.)  
Hillsdale, NJ: Erlbaum. 
*Conner, K. R., Yueying, Z., & Duberstein, P. R. (2004). NEO-PI-R neuroticism scores  
in substance-dependent outpatients: Internal consistency and self-partner 
agreement. Journal of Personality Assessment, 83(1), 75-77.  
https://doi.org/10.1207/s15327752jpa8301_07  
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997). Systematic reviews: Synthesis of 
best evidence for clinical decisions. Annals of Internal Medicine, 126(5), 376-380.  
https://doi.org/10.7326/0003-4819-126-5-199703010-00006  
Erford, B. T. (2021). Assessment for counselors. Pearson. 
Erford, B. T., Johnson, E., & Bardoshi, G. (2015). Meta-analysis of the English version 
of the Beck Depression Inventory-second edition. Measurement and Evaluation in  
Counseling and Development, 49(1), 1-31.  
https://doi.org/10.1177/0748175615596783  
Erford, B. T., Savin-Murphy, J. A., & Butler, C. (2010). Conducting a meta-analysis of  
 counseling outcome research: Twelve steps and practical procedures. Counseling 
Outcome Research and Evaluation, 1(1), 19-43.  
https://doi.org/10.1177/2150137809356682  
*Ersche, K. D., Jones, P. S., Williams, G. B., Smith, D. G., Bullmore, E. T., & Robbins,  
T. W. (2013). Distinctive personality traits and neural correlates associated with  
stimulant drug use versus familial risk of stimulant dependence. Biological  
79 
 
Psychiatry, 74(2), 137-144. http://doi.org/10.1016/j.biopsych.2012.11.016 
*Ersche, K. D., Turton, A. J., Chamberlain, S. R., Müller, U., Bullmore, E. T., & 
Robbins, T. W. (2012). Cognitive dysfunction and anxious-impulsive personality  
traits are endophenotypes for drug dependence. American Journal of Psychiatry,  
169(9), 926-936. 
*Ersche, K. D., Turton, A. J., Pradhan, S., Bullmore, E. T., & Robbins, T. W. (2010). 
Drug addiction endophenotypes: Impulsive versus sensation-seeking personality  
traits. Biological Psychiatry, 68(8), 770-773.  
https://doi.org/10.1016/j.biopsych.2010.06.015  
*Fineran, K., Laux, J. M., & Seymour, J. (2010). The Barnum effect and chaos theory: 
Exploring college student ACOA traits. Journal of College Student  
Psychotherapy, 24(1), 17-31. https://doi.org/10.1080/87568220903400096  
*Fleury, M., Grenier, G., Bamvita, J., Perreault, M., & Caron, J. (2012). Determinants  
associated with the utilization of primary and specialized mental health services.  
Psychiatric Quarterly, 83(1), 41-51. https://doi.org/10.1007/s11126-011-9181-3  
*Forbey, J. D., & Ben-Porath, Y. S. (2008). Empirical correlates of the MMPI-2  
Restructured Clinical (RC) Scales in a nonclinical setting. Journal of Personality  
Assessment, 90(2), 136-141. https://doi.org/10.1080/00223890701845161  
*Forbey, J. D., Ben-Porath, Y. S., & Arbisi, P. A. (2011). The MMPI-2 computerized  
adaptative version (MMPI-2-CA) in a veterans administration medical outpatient  
facility. American Psychological Association, 24(3), 628-639.  
https://doi.org/10.1037/a0026509   
*Forbey, J. D., Lee, T. T. C., Ben-Porath, Y. S., Arbisi, P. A., & Gartland, D. (2013).  
80 
 
Associations between MMPI-2-RF validity scale scores and extra-test measures  
of personality and psychopathology. Assessment, 20(4), 448-461. 
https://doi.org/10.1177/1073191113478154  
Galaif, E. R., Newcomb, M. D., & Carmona, J. V. (2001). Prospective relationships 
between drug problems and work adjustment in a community sample of adults.  
Journal of Applied Psychology, 86(2), 337-350. https://doi.org/10.1037//0021-
9010.86.2.337  
*Gavin, D. R., Ross, H. E., & Skinner, H. A. (1989). Diagnostic validity of the Drug  
Abuse Screening Test in the assessment of DSM-III drug disorders. British  
Journal of Addiction, 84(3), 301-307. https://doi.org/10.1111/j.1360-
0443.1989.tb03463.x   
*Gerlock, A. A. (2004). Domestic violence and post-traumatic stress disorder severity for  
participants of a domestic violence rehabilitation program. Military Medicine,  
169(6), 470-474. https://doi.org/10.7205/MILMED.169.6.470  
*Gizewski, E. R., Müller, B. W., Scherbaum, N., Lieb, B., Forsting, M., Wiltfang, J.,  
Leygraf, N., & Schiffer, B. (2013). The impact of alcohol dependence on social  
brain function. Addiction Biology, 18, 109-120. https://doi.org/10.1111/j.1369- 
1600.2012.00437.x    
Gove, W. R., Geerken, M., & Hughes, M. (1979). Drug use and mental health among a 
representative national sample of young adults. Social Force, 58(2), 572-590. 
https://doi.org/10.1093/sf/58.2.572  
Grekin, E. R., Svikis, D. S., Lam, P., Connors, V., LeBreton, J. M., Streiner, D. L.,  
81 
 
Smith, C., & Ondersma, S. J. (2010). Drug use during pregnancy: Validating the 
Drug Abuse Screening Test against physiological measures. Psychology of 
Addictive Behaviors, 24(4), 719-723. https://doi.org/10.1037/a0021741  
*Hall, J. R., Bernat, E. M., & Patrick, C. J. (2007). Externalizing psychopathology and  
the error-related negativity. Psychological Science, 18(4), 326-333.  
https://doi.org/10.1111/j.1467-9280.2007.01899.x   
Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. Academic Press. 
*Hormes, J. M., Coffey, S. F., Drobes, D. J., & Saladin, M. E. (2012). The Obsessive 
Compulsive Cocaine Use Scale: Development and initial validation of a self-rated  
instrument for the quantification of thoughts about cocaine. Drug & Alcohol  
Dependence, 120(1-3), 250-254. https://doi.org/10.1016/j.drugalcdep.2011.07.024  
*Irving, M., & Schweiger, A. (1991). Individual and family characteristics of middle  
class adolescents hospitalized for alcohol and other drug abuse. British Journal of  
Addiction, 86(11), 1435-1447. 
*Kaslow, N. J., Jacobs, C. H., Young, S. L., & Cook, S. (2006). Suicidal behavior among  
low-income African American women: A comparison of first-time and repeat  
suicide attempters. Journal of Black Psychology, 32(3), 349-365.  
https://doi.org/10.1177/0095798406290459  
Kiluk, B. D., Fitzmaurice, G. M., Strain, E. C., & Weiss, R. D. (2018). What defines a 
clinically meaningful outcome in the treatment of substance use disorders:  
Reductions in direct consequences of drug use or improvement in overall  
functioning? Addiction, 114(1), 9-15. https://doi.org/10.1111/add.14289  
*Kimbrel, N. A., Steffen, L. E., Meyer, E. C., Kruse, M. I., Knight, J. A., Zimering, R.  
82 
 
T., & Gulliver, S. B. (2011). A revised measure of occupational stress for  
firefighters: Psychometric properties and relationship to posttraumatic stress  
disorder, depression, and substance abuse. American Psychological Association,  
8(4), 294-306. https://doi.org/10.1037/0025845  
Lange, W. R., White, N., & Robinson, N. R. (1992). Medical complications of substance  
abuse. Substance Abuse, 92(3), 205-214. 
https://doi.org/10.1080/00325481.1992.11701450  
*Levy B. (2013). Autonomic nervous system arousal and cognitive functioning in  
bipolar disorder. Bipolar Disorders, 15, 70-79. https://doi.org/10.1111/bdi.12028  
Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis. Sage. 
*Looman, J. & Abracen, J. (2013). The Static-99R: Are there really differences between  
the normative groups? International Journal of Offender Therapy and  
Comparative Criminology, 57(7), 888-907.  
https://doi.org/10.1177/0306624X12443657  
Macleod, J. (2010). Drug-taking and its psychosocial consequences. In S. MacGregor  
(Ed.), Responding to drug misuse: Research and policy priorities in health and  
social care (pp. 25-39). Routledge. 
Maly, R. C. (1993). Early recognition of chemical dependence. Substance Abuse, 20(1),  
33-50. 
*Marshall, L. E., & Marshall, W. L. (2006). Sexual addiction in incarcerated sexual  
offenders. Sexual Addiction & Compulsivity, 13(4), 377-390.  
https://doi.org/10.1080/10720160601011281  
Martino, S., Grilo, C. M., & Fehon, D. C. (2000). Development of the Drug Abuse 
83 
 
Screening Test for Adolescents (DAST-A). Addictive Behaviors, 25(1), 57-70.  
https://doi.org/10.1016/S0306-4603(99)00030-1  
Minnich, A., Erford, B. T., Bardhoshi, G., & Atalay, Z. (2018). Systematic review of the  
Michigan Alcohol Screening Test (MAST). Journal of Counseling & 
Development, 96(4), 335-344. https://doi.org/10.1002/j.1556-6676.2014.00000.x  
*Møller, T., & Linaker, O. M. (2010). Using brief self-reports and clinician scales to  
screen for substance use disorders in psychotic patients. Nordic Journal of  
Psychiatry, 64(2), 130-135. https://doi.org/10.3109/08039480903274423  
*Morein-Zamir, S., Jones, P. S., Bullmore, E. T., Robbins, T. W., & Ersche, K, D.  
(2013). Prefrontal hypoactivity associated with impaired inhibition in stimulant- 
dependent individuals but evidence for hyperactivation in their unaffected  
siblings. Neuropsychopharmacology, 38(10), 1945-1953. 
* Mowbray, C. T., Bybee, D., Oyserman, D., MacFarlane, P., & Bowersox, N. (2006).  
Psychosocial outcomes for adult children of parents with severe mental illnesses:  
Demographic and clinical history predictors. Health & Social Work, 31(2),  
99-108. 
*Murphy, C. M., Taft, C. T., & Eckhardt, C. I. (2007). Anger problem profiles among  
partner violent men: Differences in clinical presentation and treatment outcome.  
American Psychological Association, 54(2), 189-200.  
https://doi.org/10.1037/0022-0167.54.2.189  
National Drug Intelligence Center. (2011). The economic impact of illicit drug use on  
American society. U.S. Department of Justice. 
National Institute of Health. (2015). 10 percent of US adults have drug use disorder  
84 
 
at some point in their lives. http://www.nih.gov/news-events/news-releases/10- 
percent-us-adults-have-drug-use-disorder-some-point-their-lives 
National Institute on Drug Abuse. (2018). Screening and assessment tools chart.  
https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-
 tools-resources/chart-screening-tools  
National Institute on Drug Abuse. (2021a). Trends & statistics: Costs of substance abuse.  
https://www.drugabuse.gov/drug-topics/trends-statistics/costs-substance-
abuse#supplemental-references-for-economic-costs   
National Institute on Drug Abuse. (2021b). Trends & statistics: National survey of drug 
use and health. https://www.drugabuse.gov/drug-topics/trends-statistics/national-
drug-early-warning-system-ndews/national-survey-drug-use-health  
* Nelson, L. D., Patrick, C. J., & Bernat, E. M. (2011). Operationalizing proneness to  
externalizing psychopathology as a multivariate psychophysiological phenotype.  
Psychophysiology, 48, 64-72. https://doi.org/10.1111/j.1469-8986.2010.01047.x  
Newcomb, M. D. (1997). Psychosocial predictors and consequences of drug use: A 
developmental perspective within a prospective study. Journal of Addictive 
Diseases, 16(1), 51-89. https://doi.org/10.1300/J069v16n01_05  
Newcomb, M. D., & Bentler, P. M. (Eds.). (1988). Consequences of adolescent drug use: 
Impact on the lives of young adults. Sage Publications. 
Newcomb M. D., & Locke T. (2005). Health, social, and psychological consequences  
of drug use and abuse. In Z. Sloboda (Ed.), Epidemiology of drug abuse  
(pp. 45-59). Springer. https://doi.org/10.1007/0-387-24416-6_4  
Newcomb, M. D., Vargas-Carmona, J., & Galaif, E. R. (1999). Psychological distress 
85 
 
among a community sample of adults: Predictors, consequences, or confound?  
Journal of Community Psychology, 27(4), 405-429. 
https://doi.org/10.1002/(SICI)1520-6629(199907)27:4<405::AID-
JCOP4>3.0.CO;2-2  
*Nochajski, T. H., Stasiewicz, P. R., & Patterson, D. A. (2013). Depression, readiness  
for change, and treatment among court-mandated DUI offenders. Journal of Dual  
Diagnosis, 9, 139-148. https://doi.org/10.1080/15504263.2013.779092  
*Nordfjaern, T. (2013). Prevalence of substance use and mental distress among patients  
on waiting lists for substance use disorder treatment. Journal of Psychoactive  
Drugs, 45(3), 233-240. https://doi.org/10.1080/02791072.2013.805977  
*Perepletchikova, F., Ansell, E., & Axelrod, S. (2012). Borderline personality disorder  
features and history of childhood maltreatment in mothers involved with child  
protective services. Child Maltreatment, 17(2), 182-190. 
https://doi.org/10.1177/1077559512448471  
*Peters, R. H., Greenbaum, P. E., Steinberg, M. L., Carter, C. R., Ortiz, M. M., Fry, B.  
C., & Valle, S. K. (2000). Effectiveness of screening instruments in detecting  
substance use disorders among prisoners. Journal of Substance Abuse Treatment,  
18, 349-358. 
Piazza, N. J., Martin, M., & Dildine, R. J. (2000). Screening instruments for alcohol and  
other drug problems. Journal of Mental Health Counseling, 22(3), 218-227. 
Plant, M. L., Plant, M. A., & Mason, W. (2002). Drinking, smoking and illicit drug use  
among British adults: Gender differences explored. Journal of Substance Abuse,  
7(1), 24-33. https://doi.org/10.1080/14659890110110392  
86 
 
Rasmussen, S. (2000). Addiction treatment: Theory and practice. Sage Publications.  
 http://doi.org/10.4135/9781452231877.n9  
*Reviere, S. L., Farber, E. W., Twomey, H., Okun, A., Jackson, E., Zanville, H., &  
Kaslow, N. J. (2007). Intimate partner violence and suicidality in low-income  
African American women. Violence Against Women, 13(11), 1113-1129. 
https://doi.org/10.1177/1077801207307798  
Robbins, C. (1989). Sex differences in psychosocial consequences of alcohol and drug  
abuse. Journal of Health and Social Behavior, 30(1), 117-130.  
https://doi.org/10.2307/2136917   
*Rosenkranz, S. E., Henderson, J. L., Muller, R. T., & Goodman, I. R. (2012).  
Motivation and maltreatment history among youth entering substance abuse  
treatment. Psychology of Addictive Behaviors, 26(1), 171-177.  
https://doi.org/10.1037/a0023800  
*Rosenkranz, S. E. Muller, R. T., & Henderson, J. L. (2012). Psychological  
maltreatment in relation to substance use problem severity among youth. Child  
Abuse & Neglect, 36(5), 438-448. https://doi.org/10.1016/j.chiabu.2012.01.005  
Sabato, T. M., Burnett, A. J., Kerr, D. L., & Wagner, L. (2013). Examining behavioral  
and psychosocial predictors of antibody testing among college youth:  
Implications for HIV prevention education and testing. American Journal of  
Sexuality Education, 8(1-2), 56-72. 
https://doi.org/10.1080/15546128.2012.740893  
Salehi, S. H., As’adi, K., Musavi, J., Ahrari, F., Nemazi, P., Kamranfar, B.,  
Gaseminegad, K., Faramarzi, S., & Shoar, S. (2012). Assessment of substance  
87 
 
abuse in burn patients by using Drug Abuse Screening Test. Acta Medica Iranica,  
50(4), 257-264. 
*Saltstone, R., Halliwell, S., & Hayslip, M. A. (1994). A multivariate evaluation of the  
Michigan Alcoholism Screening Test and the Drug Abuse Screening Test in a  
female offender population. Addictive Behaviors, 19(5), 455-462. 
*Schiffer, B., Müller, B. W., Scherbaum, N., Forsting, M., Wiltfang, J., Leygraf, N., &  
Gizewski, E. R. (2010). Impulsivity-related brain volume deficits in  
schizophrenia-addiction comorbidity. Brain: A Journal of Neurology, 133(10),  
3093-3103. https://doi.org/10.1093/brain/awq153  
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid- 
involved overdose deaths – United States, 2013-2017. Morbidity and Mortality  
Weekly Report, 67(5152), 1419-1427. 
http://doi.org/10.15585/mmwr.mm675152e1 
*Scott, D., McGilloway, S., & Donnelly, M. (2009). The mental health needs of women  
detained in police custody. Journal of Mental Health, 18(2), 144-151.  
https://doi.org/10.1080/09638230701879193  
Selzer, M. (1968). Michigan Alcoholism Screening Test (MAST): Preliminary report. 
University of Michigan Medical Center Journal, 34(3), 143-145.  
Selzer, M. (1971). The Michigan Alcoholism Screening Test: The quest for a new 
diagnostic instrument. The American Journal of Psychiatry, 127(12), 1653-1658. 
https://doi.org/10.1176/ajp.127.12.1653  
*Shuggi, R., Mann, R. E., Zalcman, R. F., Chipperfield, B., & Nochajski, T. (2006). 
Predictive validity of the RIASI: Alcohol and drug use and problems six months  
88 
 
following remedial program participation. American Journal of Drug and Alcohol  
Abuse, 32(1), 121-133. https://doi.org/10.1080/00952990500328711  
Skinner, H. A. (1982a). Guide for using the Drug Abuse Screening Test (DAST).  
  http://www.emcdda.europa.eu/html.cfm/index3618EN.html  
Skinner, H. A. (1982b). The Drug Abuse Screening Test. Addictive Behaviors, 7(4),  
363-371. https://doi.org/10.1016/0306-4603(82)90005-3  
*Skinner, H. A. (1984). Instruments for assessing alcohol and drug problems. Bulletin of  
the Society of Psychologists in Addictive Behaviors, 3, 21-33. 
*Skinner, H. A. & Goldberg, A. E. (1986). Evidence for a drug dependence syndrome  
among narcotic users. British Journal of Addiction, 81(4), 479-484. 
*St. Germain, S. A. & Hooley, J. M. (2012). Direct and indirect forms of non-suicidal  
self-injury: Evidence for a distinction. Psychiatry Research, 197(1-2), 78-84.  
https://doi.org/10.1016/j.psychres.2011.12.050  
*Stuart, G. L. & Holtzworth-Munroe, A. (2005). Testing a theoretical model of the  
relationship between impulsivity, mediating variables, and husband violence.  
Journal of Family Violence, 20(5), 291-303. 
https://doi.org/10.1007/s10896-005-6605-6  
*Sullivan, T., Cavanaugh, C., Ufner, M., Swan, S., & Snow, D. (2009). Relationships 
among women’s use of aggression, their victimization, and substance use  
problems: A test of the moderating effects of race/ethnicity. Journal of  
Aggression, Maltreatment, & Trauma, 18(6), 646-666.  
https://doi.org/10.1080/10926770903103263  
Tabachnick, B. G., & Fidell, L. S. (2019). Using multivariate statistics (7th ed.). Pearson. 
89 
 
*Teslak, A. G. (2000). The utility of the CAGE, MAST, DAST and SASSI-3 in assessing  
substance use/misuse in a psychiatric population. Dissertation Abstracts  
International: Section B: The Sciences and Engineering, 61(5-B), 2814. 
*Ting, L., Jordan-Green, L., Murphy, C. M., & Pitts, S. C. (2009). Substance use  
problems, treatment engagement, and outcomes in partner violent men. Research  
on Social Work Practice, 19(4), 395-406.  
https://doi.org/10.1177/1049731508329418  
U.S. Department of Health and Human Services (HHS), Office of the Surgeon General.  
(2018). Facing addiction in America: The Surgeon General’s spotlight on  
opioids.  https://addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-
Opioids_09192018.pdf  
U.S. Preventative Services Task Force (USPSTF). (2020). Screening for unhealthy drug  
use: U.S. Preventative Services Task Force recommendation statement. JAMA,  
323(22), 2301-2309. https://doi.org/10.1001/jama.2020.8020  
Visser, L. (1991). Drug abuse: Consequences in terms of family pathology and  
disintegration. Medicine and Law, 10, 209-212. 
Walsh, C., MacMillan, H. L., & Jamieson, E. (2003). The relationship between parental 
substance abuse and child maltreatment: Findings from the Ontario Health 
Supplement. Child Abuse & Neglect, 27(12), 1409-1425. 
https://doi.org/10.1016/j.chiabu.2003.07.002  
*Weber, G. N. (2008). Using to numb the pain: Substance use and abuse among lesbian,  
gay, and bisexual individuals. Journal of Mental Health Counseling, 30(1), 31-48.   
*Weinborn, M., Woods, S. P., Nulsen, C., & Park, K. (2011). Prospective memory  
90 
 
deficits in Ecstasy users: Effects of longer ongoing task delay interval. Journal of  
Clinical & Experimental Neuropsychology, 33(10), 1119-1128.  
https://doi.org/10.1080/13803395.2011.614595  
*Weinstein, D. W. (1999). Posttraumatic stress disorder, dissociation and substance  
abuse as long-term sequelae in a population of adult children of substance  
abusers. Dissertation Abstracts International Section A: Humanities and Social  
Sciences, 59(7-A), 2723. 
Wilson, N., Kariisa, M., Seth, P., Smith IV, H., & Davis, N. L. (2020). Drug and opioid- 
involved overdose deaths – United States, 2017-2018. Morbidity & Mortality 
Weekly Report, 69(11), 290-297. https://doi.org/10.15585/mmwr.mm6911a4  
